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A B S T R A C T
Background
Enhancing health equity has now achieved international political importance with endorsement from the World Health Assembly in
2009. The failure of systematic reviews to consider effects on health equity is cited by decision-makers as a limitation to their ability
to inform policy and program decisions.
Objectives
To systematically review methods to assess effects on health equity in systematic reviews of effectiveness.
Search methods
We searched the following databases up to July 2 2010: MEDLINE, PsychINFO, the Cochrane Methodology Register, CINAHL, Ed-
ucation Resources Information Center, Education Abstracts, Criminal Justice Abstracts, Index to Legal Periodicals, PAIS International,
Social Services Abstracts, Sociological Abstracts, Digital Dissertations and the Health Technology Assessment Database. We searched
SCOPUS to identify articles that cited any of the included studies on October 7 2010.
Selection criteria
We included empirical studies of cohorts of systematic reviews that assessed methods for measuring effects on health inequalities.
Data collection and analysis
Data were extracted using a pre-tested form by two independent reviewers. Risk of bias was appraised for included studies according
to the potential for bias in selection and detection of systematic reviews.
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Main results
Thirty-four methodological studies were included. The methods used by these included studies were: 1) Targeted approaches (n=22);
2) gap approaches (n=12) and gradient approach (n=1). Gender or sex was assessed in eight out of 34 studies, socioeconomic status
in ten studies, race/ethnicity in seven studies, age in seven studies, low and middle income countries in 14 studies, and two studies
assessed multiple factors across health inequity may exist.
Only three studies provided a definition of health equity. Four methodological approaches to assessing effects on health equity were
identified: 1) descriptive assessment of reporting and analysis in systematic reviews (all 34 studies used a type of descriptive method);
2) descriptive assessment of reporting and analysis in original trials (12/34 studies); 3) analytic approaches (10/34 studies); and 4)
applicability assessment (11/34 studies). Both analytic and applicability approaches were not reported transparently nor in sufficient
detail to judge their credibility.
Authors’ conclusions
There is a need for improvement in conceptual clarity about the definition of health equity, describing sufficient detail about analytic
approaches (including subgroup analyses) and transparent reporting of judgments required for applicability assessments in order to
assess and report effects on health equity in systematic reviews.
P L A I N L A N G U A G E S U M M A R Y
How effects on health equity are assessed in systematic reviews of effectiveness
Health in all countries of the world is unevenly and, to some extent, unfairly distributed according to socioeconomic position. Health
and longevity are highest for the richest, and decrease steadily with decreasing socioeconomic status. Avoidable and unfair inequalities
have been termed health inequities. Enhancing health equity has now achieved international political importance with endorsement
from the World Health Assembly in 2009. The failure of systematic reviews to consider effects on health equity is cited by decision-
makers as a limitation. Hence, there is a need for guidance on the advantages and disadvantages of how to assess effects on health
equity in systematic reviews.
This review identified thirty-four methodological studies in which collections of systematic reviews were examined. We identified four
methodological approaches to assess the effects on health equity, a descriptive assessment in the reviews, a descriptive assessment of the
trials included in the reviews, analytic approaches, and applicability assessment. However, the most appropriate way to address any of
these approaches is unclear. There is a need for methodological guidance on how to assess effects on health equity in systematic reviews.
Analysis of particular groups of populations need to be justified and reported in sufficient detail to allow their credibility to be assessed.
There is a need for improved transparency of judgments about applicability and relevance to disadvantaged populations.
B A C K G R O U N D
Description of the problem or issue
Health differences between groups may be due to inequalities in
factors such as socioeconomic characteristics. Health inequalities
that are unfair and avoidable are classed as health inequities.Health
inequities persist, and are worsening, across almost all health prob-
lems, both within and between countries. For example, people liv-
ing in the poorest countries have a life expectancy that is at least
40 years shorter than for people living in the richest countries.
Within a single city (Nairobi, Kenya), the mortality rate of chil-
dren younger than 5 years is 15 per 1000 in high-income areas
and 254 per 1000 in the slums (World Health Report 2008). In
an update on global trends on childmortality, inequality in under-
five mortality across sex and socioeconomic status is increasing in
more countries than it is decreasing (You 2010).
The World Health Organization convened the Commission on
Social Determinants of Health (CSDH) in 2006 and released its
final report in 2008 to assess the evidence on taking action on
reducing health inequity (Marmot 2008). The CSDH defined
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health inequity as “the poor health of poor people” both within
countries andbetween countries as due to an “unequal distribution
of power, income, goods, and services, globally and nationally,
the consequent unfairness in the immediate, visible circumstances
of people’s lives-their access to health care and education, their
conditions of work and leisure, their homes, communities, towns,
or cities-and their chances of leading a flourishing life” (Marmot
2008).
Such health inequalities need to be addressed, not only for moral
and ethical reasons, but also for economic reasons (Sachs 2001).
There is an increasing evidence-base on the effectiveness of inter-
ventions for reducing health inequities, both within and between
countries. For example, a recent systematic review, which assessed
the effects of tobacco control interventions on the socioeconomic
gradient in smoking, identified macro-level policies that may re-
duce socioeconomic differences in smoking (Thomas 2008).
There is increasing acceptance that systematic reviews of the best
available evidence are the foremost source of information onwhich
to base evidence-informed policy and practice (Lavis 2009). In-
deed, this view has been endorsed by a World Health Assembly
resolution, which was based on the Mexico Ministerial Statement
on Health Research (58th World Health Assembly Resolution). A
similar recommendation emergedduring theRole of Science in the
Information Society health conference (European Organization
for Nuclear Research 2003) that was held as part of the World
Summit of the Information Society in December 2003. The rec-
ommendation stressed the need for reliable evidence delivered in
a timely manner and in the right format. Systematic reviews are
a useful basis for decision making because they reduce the chance
of being misled, increase confidence in results, and are an efficient
use of time (Lavis 2006).
A recent study of policy maker perceptions found that policy mak-
ers increasingly consider systematic reviews as a useful source of
knowledge to support decision making (Pope 2006). However,
decision makers are interested not only in what works, but also in
the costs and resources involved in implementation and ensuring
continuity, the potential risks or adverse effects, and the distribu-
tion of benefit across sociodemographic factors (Lavis 2005). The
lack of evidence on the distribution of effects and impact on health
equity has been highlighted by policy makers as a major barrier
to the use of systematic reviews as a basis for decision making
(Petticrew 2004). Unequal benefits or harms across different so-
cioeconomic or demographic population groups could contribute
to worsening health equity (Tugwell 2006). In the context of re-
ducing health inequities, decision-makers from diverse organiza-
tions may be interested in evidence of effects of interventions on
reducing health inequity such as non-governmental organizations
and human rights organizations, as well as government decision-
makers in ministries of health and other departments (e.g. finan-
cial and agricultural) (Marmot 2008).
Health inequities are defined by Margaret Whitehead as “differ-
ences in health which are not only unnecessary and avoidable but,
in addition, are considered unfair and unjust” (Whitehead 1992).
Assessing the effects of interventions on health equity is difficult
because it requires a subjective judgment about both the avoidabil-
ity and the fairness of the distribution of effects (Kawachi 1999).
Hence, assessments of the distribution of effects of interventions
across groups of people who may experience health inequities in
both clinical trials and systematic reviews focus on differences
in health effects that can be measured (Arblaster 1996; Gepkens
1996).
The Campbell and Cochrane Equity Methods Group has adopted
the acronym PROGRESS-Plus to identify dimensions across
which health inequitiesmay exist: Place of residence (urban/rural),
Race/ethnicity,Occupation,Gender, Religion, Education, Socioe-
conomic status, and Social capital (Tugwell 2006; Evans 2003).
The “Plus” in PROGRESS-Plus refers to any additional factors
across which health inequalities may exist such as age, disability,
and sexual orientation (Kavanagh 2008). The “Plus” could also
include factors such as the experience of sexual or physical abuse
as a child, which may shape the experience of health inequity later
in life.
Despite the demand for equity assessment by policy makers, these
assessments are rare in systematic reviews. Only 1 out of 95 ran-
domly sampled Cochrane Reviews assessed differences in effects
across PROGRESS factors (Tsikata 2003). This was due to a lack
of information in the included trials (only 10% reported differ-
ences across PROGRESS factors), as well as a lack of assessment
by the review authors (Tsikata 2003).
Description of the methods being investigated
The differentmethods used to describe and assess effects on health
inequalities in systematic reviewswere investigated. Because health
equity requires a subjective judgment about whether differences
in health outcomes are unfair, this review focused on the assess-
ment of health inequalities across PROGRESS-Plus factors. We
chose PROGRESS-Plus as an organizing framework to assess di-
mensions across which health inequities exist since it is endorsed
by the Campbell and Cochrane Equity Methods Group and also
encompasses the factors suggested by the World Health Organi-
zation Commission on Social Determinants of Health (Tugwell
2010). We also assessed whether the authors of the included stud-
ies described inequalities in health outcomes as unfair and unjust.
There are a number of ways to measure health inequalities. For
example, health inequalities can be expressed as the difference be-
tween the most and least advantaged groups in relative or abso-
lute terms (Keppel 2005), or they can be expressed using more
complicated indices such as the Gini index, concentration index
(Koolman 2004), or benefit-incidence estimate (Wagstaff 2005).
The choice of method and comparator or reference group in-
fluences both the magnitude of the result and its interpretation
(Keppel 2005). See Table 1 for selected methods of assessing ef-
fects on health inequalities.
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How these methods might work
Relative or absolute differences for health inequalities measured
over time can demonstrate either an increase or decrease in health
inequalities for the same data, because relative measures are af-
fected by the underlying rate of the reference group. A detailed ex-
ample of this can be found in Table C of Keppel 2005. Economic
measures of health inequalities, such as the Gini index, concentra-
tion index, and the benefit-incidence ratio, may be too complex
to interpret and require too many data points to be useful in the
context of systematic reviews (Tugwell 2006). This methodology
review sought to assess whether these methods have been used to
assess health inequalities in empirical studies analyzing systematic
reviews, and to explore the advantages and disadvantages of each
method.
Why it is important to do this review
Despite the demand for health equity assessment in systematic
reviews by policy makers and practitioners, there remains little
empirical evidence on which of the different methods available
for assessing health inequalities are have been used in the context
of systematic reviews of effectiveness, and their advantages and
disadvantages.
O B J E C T I V E S
We aimed to describe and assess the effects of using differentmeth-
ods to assess health inequalities in empirical research studies of
systematic reviews of the effectiveness of interventions. Thus, we
aimed to assess whether the authors of the systematic reviews in-
cluded in the methodology studies presented results on the effects
of the interventions for groups of people who could be classified
as suffering from health inequity, across one or more of the so-
ciodemographic factors of PROGRESS-Plus.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included empirical studies of a cohort (more than one) of sys-
tematic reviews of health or non-health interventions that assess
effects on health across one or more socioeconomic and demo-
graphic factors defined by PROGRESS-Plus. The empirical stud-
ies needed to assess whether authors of the included systematic
review presented or discussed results on the effects of interven-
tions for groups of people who could be classified as suffering from
health inequity, across one or more of the sociodemographic fac-
tors of PROGRESS-Plus. Empirical studies using qualitative or
quantitative approaches were eligible.
Empirical studies could assess the effects of interventions that aim
to decrease the category health inequity experienced by a group
of people, such as interventions which aim to improve education
opportunities or reduce poverty, if they measured effects on health
outcomes of these interventions (Gakidou 2010). An example of
an eligible study is an empirical study which assessed the the effects
of community-based tobacco control interventions for groups of
people who could be defined as experiencing health inequity across
sex, race/ethnicity or socioeconomic status in six Cochrane reviews
(Ogilvie 2004).
We excluded individual systematic reviews assessing health in-
equalities as we aimed to assess methods for comparing health in-
equalities across different systematic reviews, rather than within
an individual systematic review. Furthermore, including individ-
ual systematic reviews might introduce bias because they are less
likely to report health inequalities analyses when no substantive
differences are found (Chan 2004).
Overviews of systematic reviews synthesize evidence frommultiple
systematic reviews of interventions into one document (Cochrane
Handbook 2009). Overviews of systematic reviews were eligible
if they assessed effects of interventions for groups of people who
could be classified as suffering from health inequity.
Types of data
We assessed data from published or unpublished empirical studies
of a cohort of systematic reviews on the advantages, disadvantages
and feasibility of methods used to assess effects of interventions
in groups of people who could be defined as experiencing health
inequity. We extracted data on the advantages and disadvantages
(or strengths and limitations) of each of the methods as described
by the authors of the empirical studies. We used PROGRESS-
Plus to categorize groups of people who might experience health
inequity. The place of residence of high-income country compared
to low and middle income country was also considered as a factor
across which health inequity may exist. We used the classification
of the World Bank for high, middle and low income countries.
Since the political climate of a country interacts with the income
level of the country in relation to the existence of health inequities,
we considered differences in political stability and climate in the
“Plus” factor of PROGRESS-Plus. For example, although Saudi
Arabia is a high-income country, the experience of health inequity
by religious groups and women is different than in a Western
industrialized country.
For the health inequalities to be judged inequitable, unfairness
and avoidability (or remediability) need to be assessed. Therefore,
we assessed whether the empirical studies of cohorts of systematic
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reviews included a judgment about the fairness and avoidability of
health differences. If the studies made no judgment about health
equity, we used the Whitehead criteria of avoidability and unfair-
ness to make a judgment about whether health differences across
these factors for the particular intervention and setting could be
considered health inequities (Whitehead 1992). Judgments made
using these criteria were documented, includingwhether sufficient
information was available to make such a decision. For example,
sex differences that are due to unavoidable underlying differences
in biology would not meet the criteria for a health inequity, such as
differences in rates of breast cancer across sex, or manifestations of
haemophilia in males (Whitehead 1992). We expected substantial
heterogeneity in definitions of equity. Therefore, we documented
the variety of existing definitions to help inform the development
of universally accepted definitions.
Empirical studies of cohorts of systematic reviews were included
if they focused on the following:
1. Targeted approaches: evaluating effects (benefits or harms)
in disadvantaged populations only (i.e. populations who suffer
from health inequity due to their characteristics across one or
more of PROGRESS-Plus factors).
2. Gap approaches: evaluating differences in effects (benefits
or harms) between the most and least advantaged groups (see
Table 1).
3. Gradient approaches: evaluating effects (benefits or harms)
on the gradient from the most disadvantaged to the least
disadvantaged groups (Table 1).
Types of methods
We compared different methods used by the empirical studies for
assessing effects on health inequalities in terms of: the expertise
required to implement the strategy at the level of the overview/
empirical study; the availability of data from the systematic reviews
as assessed by the authors of the empirical study; their advantages
and disadvantages; and whether and how judgments about health
equity are made (e.g. judgments about fairness and avoidability of
differences in benefits or harms).
Types of outcome measures
Primary outcomes
• Advantages and disadvantages of the methods used for
assessing health inequalities, based on descriptions of the authors
of the empirical studies and a judgment by the data extractors
assessed from the perspective of a user of the empirical study.
This judgment was made by asking the data extractors to
consider a decision-maker’s perspective. These judgments were
compared and agreed to. We also discussed these judgments with
other authors who were not responsible for the data extraction.
• Whether the analyses of effects on health inequalities across
PROGRESS-Plus factors met the following criteria for credible
subgroup analyses, as recommended by the Cochrane Handbook
(Oxman 1992, Cochrane Handbook 2009).
i) Clinically important difference.
ii) Statistically significant difference.
iii) A priori hypothesis.
iv) Subgroup analysis is one of a small number of
hypotheses tested.
v) Difference suggested by comparisons within primary
studies of meta-analyses.
vi) Difference consistent across primary studies of meta-
analyses.
vii) Indirect evidence that supports hypothesized
difference.
Four additional criteria have been proposed since this protocol
was written for assessing the credibility of subgroup analyses: 1)
consideration of baseline characteristics; 2) independence of the
subgroup effect (i.e. the subgroup effect is not confounded by
association with another factor); 3) a priori specification of the
direction of effect; and 4) consistency across related outcomes (Sun
2010). These four criteria have not been assessed. They will be
included in the first update of this review.
Secondary outcomes
• Whether and how health inequity was defined and
measured (e.g. whether proxy measures, such as nutritional
status, are used).
• Information on the availability of data from primary trials
or meta-analyses to conduct analyses across PROGRESS-Plus
factors.
• What factors are associated with health inequalities (e.g. the
types of primary studies included in the systematic reviews and
implementation factors, such as the degree to which flexibility
was allowed in the implementation).
• Implications for practice, policy, and research based on
analysis of effects on health inequalities.
Search methods for identification of studies
The search strategy was developed by one author (VW) using a
systematic scoping exercise to assess the effects of different MeSH
terms and the use of limits on publication type (i.e. limited to
meta-analyses or systematic reviews) and type of studies (i.e. in-
tervention studies). The terms developed for equity were based
on the elements of PROGRESS-Plus, and testing that our group
has done on the use of filters for health equity (McGowan 2003).
We tested the inclusion of a term related to geographic disparities
(including terms such as resource-poor settings and low and mid-
dle income countries) because the search was very broad without
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using restrictions. We tested this strategy to ensure that known rel-
evant studies were retrieved, including one study of the assessment
of low and middle income country concerns in systematic reviews
(Nasser 2007). The final search strategy does not include limita-
tions on publication type as these were found to be too restric-
tive. An information scientist (JM) reviewed the search strategy, as
recommended by the Peer Review of Electronic Search Strategies
(PRESS) guidelines (Sampson 2008).
The search strategy was not limited by publication type or study
design as there is no indexing term for studies that assess cohorts
of systematic reviews. We included published and unpublished
articles, as well as abstracts.
Electronic searches
We searched:
• the Cochrane Methodology Register (to July 2, 2010);
• MEDLINE (January 1950 to July 2, 2010) using the Ovid
interface;
• EMBASE (1980 to July 2, 2010) using the OVID interface;
• PsycINFO (1806 to July 2, 2010) using the OVID interface
• CINAHL (1998 to July 2, 2010).
See Appendix 1 for the MEDLINE search strategy.This search
strategy was adapted for the other electronic databases (Appendix
2).
To identify systematic reviews of social, legal, and educational
interventions, we searched non-health literature databases using
the Scholars Portal interface including the Education Resources
Information Center (ERIC, 1965 to July 2, 2010), Education Ab-
stracts (1983 to July 2, 2010), Criminal Justice Abstracts (1968 to
July 2, 2010), Index to Legal Periodicals (1994 to July 2, 2010),
PAIS International (public affairs, public and social policies, in-
ternational relations - 1972 to July 2, 2010), Social Services Ab-
stracts (1979 to July 2, 2010), Sociological Abstracts (1952 to July
2, 2010), and Digital Dissertations (1997 to July 2, 2010). We
also searched the reports of national health technology assessment
organizations using the Health Technology Assessment Database
(available on the Cochrane Library) to July 2, 2010.
Searching other resources
We also handsearched abstracts from recent Cochrane and Camp-
bell Collaboration Colloquia (2007 to 2010).
We used SCOPUS to identify citations of potentially included
studies. SCOPUS is a citation tracking database of over 18,000
titles across scientific, technical, medical and social sciences fields
as well as arts and humanities. We conducted a search of SCOPUS
for all included studies on October 7 2010. This identified any
articles which had cited one of the included studies.
We searched the reference lists of included studies for other poten-
tially relevant studies, and we contacted the authors of included
studies to ask if they knew of similar studies.
We also asked the editorial board members of the Cochrane and
Campbell Equity Methods Group whether they were aware of
other potentially relevant studies.
Unpublished studies and abstracts were identified through the
methods above of contacting experts, authors and searching con-
ference proceedings of the Cochrane and Campbell Colloquia.
Data collection and analysis
Selection of studies
Two review authors (chosen from EU, JdM, MB, BD and VW)
independently screened the titles and abstracts of all references
retrieved by the search strategy to exclude those thatwere obviously
irrelevant. They were not blinded to the authorship of the titles
and abstracts because this is difficult to achieve and may not affect
the screening process (Berlin 1997).
Potentially relevant articles were retrieved and screened indepen-
dently by two review authors (chosen from EU, JdM, BD, MB,
and VW) using an eligibility checklist. Disagreements were re-
solved by consensus in consultation with another author (MP or
PT). We documented all reasons for exclusion at both stages of
screening for entry into a PRISMA (Preferred Reporting Items for
Systematic reviews and Meta-Analyses) flowchart (Moher 2009).
Data extraction and management
Two review authors (chosen from EU, JdM, MB, and VW) ex-
tracted data independently from the included empirical studies us-
ing a pre-tested data extraction form designed in an Excel spread-
sheet (see Appendix 3), which was used to manage and summarize
data. For consistency, VW extracted data from each study. The as-
signment of articles to the other data extractors was based on their
time available to contribute. We compared the data extracted by
both review authors for each study. Disagreements were resolved
by consensus. Another author (MP or PT) mediated when con-
sensus could not be reached.
We extracted data on:
1. how the sample of systematic reviews was selected;
2. the characteristics of the systematic reviews (population,
intervention, comparison, outcomes, study designs included,
quality assessment, year of publication);
3. characteristics of the interventions being studied (e.g.
pharmacologic, implementation, health services);
4. the method used to assess effects on health equity (how and
whether equity is defined; which elements of PROGRESS-Plus
were compared; whether other factors, such as the study design
of primary studies, setting, or context, were assessed that might
explain differences in effects across PROGRESS-Plus factors);
5. how effects were compared (e.g. relative or absolute
differences, or gradient approaches such as the Gini coefficient);
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6. the size of the difference in effects across different
populations defined by PROGRESS-Plus.
We also assessed whether data on PROGRESS-Plus was available
from the systematic reviews, as reported by the authors of the em-
pirical studies.. We did not verify this data availability by consult-
ing the systematic reviews.
Assessment of risk of bias in included studies
Two of the four possible reasons for systematic error or bias were
addressed: selection bias and detection bias (Higgins 2008). For
each of these possible sources of bias, we assessed the transparency
of the methods described by the authors and the potential for bias
in the methods used to select and analyze the systematic reviews
included in the cohort. We did not assess performance bias as this
is related to exposure to the intervention in randomized controlled
trials and does not apply to empirical studies of cohorts of system-
atic reviews. In the context of empirical studies designed to assess
health inequalities in cohorts of systematic reviews, selection and
detection bias were defined as follows.
• Selection bias: potential for bias in the selection of the
systematic reviews to be included or excluded. We extracted
details on the inclusion and exclusion criteria used to select
systematic reviews.
• Detection bias: potential for bias in the assessment of
analytic methods and outcomes in cohorts of systematic reviews.
We extracted information on how the details of the analysis of
effects on health equity were extracted from the systematic
reviews.
Wedidnot assess attritionbias because in the context of this review,
attrition bias (defined as systematic differences between groups in
withdrawals) refers to the same concept as selection bias.
Measures of the effect of the methods
We conducted a comparative analysis of the methods used to as-
sess effects on health inequalities by comparing the advantages and
disadvantages of each of the methods, as judged by the data ex-
tractors, based on the description by the authors of the empirical
studies and considering the perspective of the reader or user of the
empirical study.
We extracted details reported by the authors of the empirical stud-
ies on the availability of data from the systematic reviews and their
included primary studies, as well as on the methods used to com-
pare differences in disadvantaged populations to the overall pooled
effect.
We also compared any subgroup analyses against the seven cri-
teria for credible subgroup analyses and four additional criteria
(Oxman 1992, Sun 2010). Additional criteria for subgroup anal-
yses for clinical trials and meta-analyses were also considered for
this comparison (Rothwell 2005; Thompson 2005).
Dealing with missing data
We planned to contact authors of the included studies if insuf-
ficient information was available regarding sample generation,
methods, and outcomes. We only contacted one author for ad-
ditional information, to request the criteria used to assess appli-
cability and equity (Althabe 2008). These authors provided their
checklists.
Assessment of heterogeneity
Results were not pooled. Results for each outcome (e.g. data
availability, advantages, disadvantages, and credibility of subgroup
analyses) were presented across each factor of PROGRESS-Plus
for each included study.
Assessment of reporting biases
Reporting bias occurs when dissemination of research findings is
influenced by the nature and direction of results (Higgins 2008).
Positive studies, in the context of this review, include studies that
are able to show statistically significant and substantive differences
in effects across one or more PROGRESS-Plus categories. We at-
tempted to minimize the identification of only studies with pos-
itive results by using a comprehensive search strategy in diverse
electronic databases, assessing relevant conference proceedings, re-
viewing citations, and contacting both the authors of eligible em-
pirical studies and other experts.
Data synthesis
Results were synthesized in tables. Where data were available on
subgroup analyses, we summarized the methods used to compare
effects in different populations across PROGRESS-Plus categories.
For subgroup analyses, we assessed the first criteria of clinical im-
portance of the difference in effects by assessing whether the au-
thors of the empirical study described the clinical importance. If
the authors did not judge the clinical importance, we compared
the pooled effect size to the effect size reported in the different
subgroups, either using mean differences or risk ratios and their
95% confidence intervals (CIs).
Subgroup analysis and investigation of heterogeneity
As this is a descriptive methodology review, the results were not
pooled and subgroup analyses was not conducted.
Sensitivity analysis
As this is a descriptive methodology review, the results were not
pooled and sensitivity analyses were not conducted.
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R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
10,058 potential articles were screened for inclusion (Figure 1).
Of these, 102 potentially eligible studies were retrieved in full text.
Figure 1. Figure 2: PRISMA Chart
Included studies
Thirty-four empirical studies (described in 37 articles) of cohorts
of systematic reviews were included which assessed effects on
health inequalities across one or more PROGRESS-Plus factor.
These included studies were identified by electronic databases (n=
25), searching SCOPUS for references to included studies (n=5)
(Barros 2010;Doull 2010; Bhutta 2008;Chopra 2008; Ball 2002),
handsearching reference lists (n=2) (Shea 2009, Jones 2003) and
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contact with experts (n=2)(Bambra 2010; Odierna 2009). One
ongoing doctoral thesis study assessing equity aspects in health
technology assessment reports was identified (Panteli 2009). Four
studies were identified as abstracts (Odierna 2009, Nasser 2007,
Tsikata 2003, Doull 2010). Two studies remained unpublished
except as abstracts, as of publication of this review (Nasser 2007,
Tsikata 2003).
The methods used by these included studies were: 1) Targeted
approaches (n=22); 2) gap approaches (n=12) and gradient ap-
proach (n=1). One study was classified as both a gap approach
and a targeted approach (Sherr 2009), since it assessed differences
in effects across sex (gap approach), as well as effects of interven-
tions aimed only at women (targeted approach). Gender or sex
was assessed in eight out of 34 studies, socioeconomic status in
10 studies, race/ethnicity in seven studies, age in seven studies,
LMIC in 14 studies, and two studies assessed all PROGRESS-Plus
factors. The rationale for assessing effects on health inequalities
in these studies was to better understand the mechanism of action
of the intervention in five studies, to improve understanding of
what works to reduce health inequalities in ten studies, to assess
direct evidence on effectiveness in particular populations in nine
studies, and to assess applicability or relevance of evidence for dis-
advantaged populations or settings in ten studies. The number
of meta-analyses or systematic reviews included in these studies
ranged from 5 to 420 systematic reviews. Six out of 34 of these
studies assessed cohorts of exclusively Cochrane reviews.
We included nine overviews of effectiveness of interventions to im-
prove maternal, neonatal and child health with a focus on LMIC.
These overviews are the studies from theGlobal report on prevent-
ing preterm birth and stillbirth (Barros 2010), the Lancet child
survival series (Jones 2003), the Lancet series on Alma-Ata rebirth
and revision (Bhutta 2008), the Lancet neonatal survival series
(Darmstadt 2005), the Lancet maternal and child undernutrition
series (Bhutta 2008), and the Biomed Central series on reduc-
ing stillbirths (Bhutta 2009, Haws 2009, Menezes 2009, Yakoob
2009). These overviews of effectiveness were based on a combi-
nation of systematic reviews, randomized trials and observational
studies, with particular emphasis on effectiveness and relevance in
LMIC. The systematic reviews cited for these series drew heavily
on Cochrane reviews since they were considered high quality and
reliable systematic reviews by the authors of these series (for exam-
ple, 81/102 systematic reviews cited in the 2009 Biomed Central
reducing stillbirths series were Cochrane reviews).
Excluded studies
65 studies that were retrieved in full text were excluded. 57 studies
were excluded since they clearly did not meet the inclusion criteria
because they were not cohorts of systematic reviews (n=38) or
because they did not assess health inequalities across one or more
PROGRESS-Plus factor (n=19). Eight studies which appeared to
meet both of these inclusion criteria, but on closer examination
failed, are described in the Table of Excluded Studies.
Five studies were excluded since they did not describe a focus on
health equity (Gulmezoglu 1997; Barlow 2004; Espinosa-Aguilar
2007; Craig 2003; Gaes 1999) (See Table of Excluded Studies).
These studies assessed health effects of interventions in specific
populations that could be classified as vulnerable across one or
more PROGRESS-Plus factor (e.g. sexual offenders, elderly, chil-
dren with chronic disease), but the authors of the study did not
describe a focus on vulnerability or disadvantage. Two studies of
cohorts of systematic reviews were excluded since they did not as-
sess health inequalities (Ahmad 2010, AHRQ 2010). One study
that assessed health inequalities was excluded since it was a single
systematic review of multiple interventions, not a cohort of sys-
tematic reviews (Thomas 2008).
Risk of bias in included studies
From the reporting of each cohort, we assessed the risk of selection
bias to be low for 27 out of 34 included studies (Figure 2). These
27 empirical studies of a cohort of systematic reviews reported
using an explicit search method, and screening titles for inclusion
using prespecified criteria to identify relevant systematic reviews.
Detection bias was low for 11 out of 34 of the included studies
which reported explicit methods of data extraction, using forms
and data verification. The other 23 studies did not fully report
methods for data extraction and verification, and may be subject
to a higher risk of bias due to missing relevant information.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Across studies, there is a low risk of selection bias since all of these
empirical studies of cohorts of systematic reviews used a systematic
search to identify studies that met predetermined criteria. Six out
of 34 of these studies assessed solely cohorts of Cochrane system-
atic reviews which may be least likely to assess effects on health
inequalities since they are most likely to assess efficacy questions
where differences in effectiveness across PROGRESS-Plus factors
are least likely to occur (Tugwell 2008).
Effect of methods
Definition of health equity
Equity was defined in three studies, as unfair and avoidable in-
equalities in health across socioeconomic strata (Tugwell 2008;
Tsikata 2003; Odierna 2009). None of the studies described
making a judgment about the fairness of differences in health.
Twelve studies describe higher burden of disease in disadvantaged
populations as avoidable or preventable, without making a state-
ment about fairness or justice. One study described using an “eq-
uity lens” (Main 2008) to assess whether systematic reviews could
be used to answer questions about reducing health inequalities
across SES, ethnicity or education. Three studies used the “SUP-
PORT equity checklist” (Lewin 2008; Althabe 2008; Chopra
2008) which assesses access to health care across LMIC, gender,
age, ethnicity or SES (Appendix 4). Three studies focused on
assessing differences across gender or sex by conducting a gender
analysis (Johnson 2003, Sherr 2009) or gender and sex based anal-
ysis (Doull 2010). In one study, the rationale for conducting a
gender analysis was due to differences in biological susceptibility
HIV/AIDS as well as the social susceptibility through gender roles
anddiscrimination (Sherr 2009).Nine studies focused on assessing
relevance of systematic reviews for decisions about health care in
low and middle income countries (LMIC)(Nasser 2007; Tugwell
2008; Tsikata 2003; Chopra 2008; Menezes 2009; Bhutta 2009;
Haws 2009; Darmstadt 2009; Yakoob 2009). Two of these stud-
ies described differences in access to health care across geography
and socioeconomic status in LMIC as inequitable (Lewin 2008;
Chopra 2008).
Methods identified to assess consideration of effects
on health inequalities or health inequities
We identified four categories of methods used to assess whether
systematic reviews considered effects of interventions on health
equity: 1) descriptive assessment of systematic reviews; 2) descrip-
tive assessment of primary studies included in the systematic re-
views; 3) analytic approaches and 4) judgment of applicability to
disadvantaged populations or settings. See Table 2.
1) Descriptive assessment of systematic reviews
All 34 studies used at least one of the five descriptive approaches
described below to assess whether their sample of SRs had consid-
ered effects of interventions on health equity.
1a) Mention of PROGRESS-Plus in introduction, objectives,
discussion, implications
Only three methodological studies included in their objectives the
assessment of explicit mention of PROGRESS-Plus in the intro-
duction, objectives or discussion. This strategy provides informa-
tion about whether SRs consider health equity in a broad sense,
but provides no evidence on effects on health equity.
1b) Methods study assessed whether SRs describe populations
in the primary studies across PROGRESS-Plus factors
For the twelve empirical studies which used this method, details
on the populations included in the trials were available for 0%
to 57% of SRs across PROGRESS-Plus factors. Sex distribution
of the population was the most well-reported PROGRESS-Plus
factor (90/153 SRs). The advantage of this approach is that in-
formation about the diversity of populations increases confidence
in applying results across different populations and settings. The
disadvantages are lack of data, and that description of populations
does not assess differences in effects across these populations.
1c) Methods study assesses whether SR describes primary
research as targeted at disadvantaged populations across
PROGRESS-Plus
Twenty-two methodology studies assessed whether systematic re-
views described interventions as being evaluated in specific disad-
vantaged populations. Of these, seven methodology studies se-
lected SRs which focused only on disadvantaged populations (tar-
geted). The disadvantaged populations targeted in these seven
methodology studies were elderly with mental health problems
(Adamek 2008; Bartels 2003), youth with disabilities (Stewart
2006), socially disadvantaged mothers (D’Souza 2004), people in
low and middle income countries (Nasser 2007), women at risk
for low birth weight children (Ball 2002), and minority popula-
tions, injection drug users and people with HIV (Vergidis 2009).
These methodology studies described these populations as disad-
vantaged because of avoidable and unfair poorer health outcomes
than other people due to lack of evidence, lack of guidelines or
lack of resources to access and use preventive and curative inter-
ventions.
Ten methodology studies reported assessing whether the SRs de-
scribed at least one study conducted in a disadvantaged popula-
tion. While this descriptive method identifies whether interven-
tions have been evaluated in disadvantaged populations, it does
not assess the effects on health inequalities. Furthermore, it can be
misleading since SRs with no studies in disadvantaged populations
may still be relevant and applicable to disadvantaged populations.
1d) Methodology study assessed whether SRs have outcomes
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related to equity of access
Seven methodology studies described whether SRs reported out-
comes related to access to care or coverage of health services. Ac-
cess to health care across disadvantaged groups (e.g. rural, low SES,
LMIC, ethnicity) was reported in 18/173 SRs in these methodol-
ogy studies. Access to health care is a determinant of both health
and health inequalities. This strategy does not measure effects on
health equity. Evidence on access to care may be affected by the
eligibility criteria of the methodology studies. For example, one
methodology study required that SRs contain information about
access to care in LMICs by the focus of the review (Lewin 2008).
1e) Methodology study assesses whether SRs planned or con-
ducted subgroup analyses across one or more PROGRESS-
Plus factors
Ten methodology studies assessed whether subgroup analysis was
conducted in groups of SRs. Outcomes were analyzed using sub-
group analysis across one or more PROGRESS-Plus factor in only
22 out of 262 SRs assessed in thesemethodology studies (8%). For
those that reported details of these subgroup analyses, subgroup
differences were assessed across gender/sex (n=15), race/ethnicity
(n=12) and socioeconomic status (n=1). Differences in effects
across other factors of PROGRESS-Plus were not reported at the
level of the SR in these methodology studies (LMIC, place of res-
idence, occupation, religion, social capital). The advantage of this
strategy is that subgroup analysis summarizes the data available in
specific populations. However, these subgroup analyses are lim-
ited in their ability to detect differences due to statistical issues
(e.g. post-hoc analyses, probability of finding a false association,
lack of data in the primary studies, or lack of reporting stratified
data in primary studies) (Bambra 2010). Furthermore, subgroup
analyses that were conducted were poorly reported (Table 3).
2) Descriptive assessment of primary studies included in the
systematic reviews
2a) Methodology study assesses whether populations in pri-
mary studies are described according to PROGRESS-Plus:
Elevenmethodology studies retrieved and evaluated primary stud-
ies of included SRs to assess whether data was available from pri-
mary studies to conduct subgroup analyses in SRs. Population
characteristics were reported in primary studies for sex most fre-
quently (209/250 trials), followed by race, education, place of res-
idence, socioeconomic status, occupation and social capital. This
strategy has the advantage of assessing whether data is available in
primary studies, thus assessing whether there is a risk of bias that
PROGRESS-Plus characteristics are under-reported in systematic
reviews (Bambra 2010; Tugwell 2008). However, this strategy
does not assess effects on health inequalities, and data may not be
available from the primary studies stratified by PROGRESS-Plus
characteristics.
2b) Methodology study assesses whether subgroup analyses
conducted in primary studies:
Six of the methodology studies of systematic reviews assessed
whether data was available from the primary studies on popu-
lation characteristics across PROGRESS-Plus and whether out-
comes were analyzed using subgroup analysis in the primary stud-
ies (Tsikata 2003). In the included primary studies, outcomes
were reported separately for sex most commonly (from 13-36% of
clinical trials), followed by SES (4 out of 103 trials in one study).
Advantages of this approach are that more details are available re-
garding the methods of subgroup analyses by assessing informa-
tion in the primary studies than in systematic reviews. Disadvan-
tages of this approach are that it is time-consuming to locate and
assess all primary studies (Bambra 2010; Ogilvie 2004b).
3) Analytic approaches
3a) Methodology study to assess association of PROGRESS-
Plus factors with size of effect
Regression analysis was used by one methodology study of SRs
on interventions to improve adherence (Morrison 2004). Data
was available for age (8 out of 12 SRs), sex (7 out of 12 SRs) and
socioeconomic status (5 out of 12 SRs). One study categorized
the effect of gender on outcomes as positive effect, negative effect
or no effect (Sherr 2009).
Advantages of assessing association of PROGRESS-Plus factors
with size of effect are that it could be used to assess which
PROGRESS-Plus factors are associated with effects on health eq-
uity and the dose-response of their effect. The disadvantage of
this approach is that data may be unavailable (e.g. in Morrison
2004, one third of SRs lacked data to conduct this analysis).
3b) Methodology study compares effect size using an odds
ratio, relative risk or risk difference between two groups across
PROGRESS-Plus (e.g. men vs. women)
None of the 34 methodology studies reported a quantitative com-
parison of the difference between advantaged and disadvantaged
populations or settings.
3c) Methodology studies assessed effects of interventions tar-
geted at a specific population which is disadvantaged (e.g.
older people with depression, youth with disabilities).
Seven methodology studies searched for systematic reviews of the
effects of interventions targeted at populations which were de-
scribed by the authors as disadvantaged by unequal opportuni-
ties for optimal health or high quality health care. One study
(Vergidis 2009) assessed effects of interventions to reduce high-
risk behaviours in specific populations that are widely acknowl-
edged as disadvantaged (i.e. minority populations, injection drug
users, men who have sex with men and people with HIV), but did
not make any judgment or statement about vulnerability of these
populations. These methodological studies identified a median of
11 SRs (range 5-23), and four studies reported clinically impor-
tant and statistically significant effect sizes in these populations.
The advantage of this approach is that evidence on effectiveness
can be directly used to inform decisions about interventions aimed
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at specific disadvantaged populations (e.g. older people with de-
pression) (Adamek 2008) and to identify gaps in the evidence-
base. However, this approach may not be possible for some disad-
vantaged groups where systematic reviews or primary trials have
not been conducted. Furthermore, this approach is limited by the
methodological quality of the SRs and whether sufficient details
about the process of implementation are reported to replicate the
interventions. Also, the gap or gradient between these disadvan-
taged populations and others is not assessed, so the extent to which
interventions generate health inequalities is not assessable (Adams
2005).
4) Judgment of applicability to disadvantaged populations or
settings
4a) Methodology studies assess applicability to different pop-
ulations across PROGRESS-Plus
Eleven methodology studies assessed the applicability and rele-
vance of systematic reviews to improve health of people in LMIC
(Althabe 2008; Lewin 2008; Chopra 2008). Three methodology
studies all used the SUPPORTCollaboration checklists for equity,
applicability and scaling up to make judgments about whether
the results from systematic reviews could be transferred to LMIC
settings and could be expected to confer health benefits (details
of SUPPORT checklists available in Appendix 4, and at: http://
www.support-collaboration.org/summaries/methods.htm).
Five studies used the SIGN tools to assess quality and strength of
the evidence, including the directness of evidence toLMIC settings
(see Appendix 5 andAppendix 6 for details about howapplicability
and generalizability are assessed using considered judgment).
Three studies used the GRADE tools to assess quality of evidence
for each outcome. The GRADE assessment also includes an as-
sessment of directness of evidence to the population of interest,
which was people in LMIC in these studies (Lewin 2008, Bhutta
2008, Barros 2010). These three studies do not report how this
judgment was made, or when the difference between people in the
trials included in the systematic reviews would be large enough to
downgrade the quality of evidence for indirectness.
Two studies used criteria of biological plausibility and feasibility
of implementation in LMIC to select interventions. These criteria
were judged by a panel of experts using Delphi consensus methods
(Jones 2003, Darmstadt 2005). These authors do not report how
these judgments were made, nor whether there was discrepancy in
opinion in making these judgments.
Studies which assessed applicability described difficulty in mak-
ing judgments about applicability of interventions in different set-
tings than the settings where the primary studies were conducted
(for example, Althabe 2008 describes difficulty in assessing appli-
cability because the context and setting is different in Argentina
than in other low and middle income countries). For judging the
relevance and applicability to LMIC, there was limited evidence
on real-world effectiveness in LMIC, thus the authors relied on
efficacy data from systematic reviews as well as expert opinion
(Darmstadt 2005). For example, some interventions require ac-
cess to highly skilled professionals, equipment or emergency trans-
portation whichmay not be available in LMIC (Darmstadt 2009).
For example, smoking cessation trials have almost all been con-
ducted in high-income countries, and their applicability to low
and middle income country settings is questioned because risk
factors may be different for women in low and middle income
countries (Yakoob 2009).
Advantages of judging applicability to disadvantaged populations
and/or settings are that it makes use of the best available evidence
to make judgments that can be used to inform policies. Dis-
advantages are that the judgment of applicability and equity are
extremely challenging and requires content expertise, knowledge
of LMIC settings and methodological knowledge (Althabe 2008).
Furthermore, assessing applicability does not assess the likelymag-
nitude of effects and, since LMIC settings are extremely hetero-
geneous, the judgments required for these checklists need to be
framed for specific settings.
Comparison against the “seven rules of when to
believe a subgroup analysis”
For the elevenmethodology studieswhich reported subgroup anal-
yses in SRs across a PROGRESS-Plus factor, we assessed whether
these analyses met the Oxman and Guyatt seven credibility cri-
teria of when to believe a subgroup analysis (Table 3) (Oxman
1992). We also assessed two additional criteria suggested by Roth-
well that subgroup analyses should be tested with a subgroup by
treatment interaction and that randomization of trials should be
stratified across the intended subgroup analyses (Rothwell 2005).
The eleven methodology studies provided insufficient data to as-
sess seven out of nine criteria. Five studies provided a rationale to
support the subgroup analyses, four studies described an a priori
hypothesis, three studies reported statistical or clinically important
differences, without details on the type of statistical test. None of
these methodological studies described whether the differences as-
sessed by subgroup analyses were due to differences in absolute ef-
fects (e.g. because of higher baseline risk in disadvantaged groups)
or relative effects (e.g. because of different mechanisms of action).
Factors associated with differences in effects
None of the methodological studies described factors that
might plausibly be associated with differences in effects across
PROGRESS-Plus.
D I S C U S S I O N
Systematic reviews represent an opportunity for increasing the
ability to detect subgroup differences because they include stud-
ies conducted in diverse settings and populations(Glasziou 2002).
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These systematic reviews can increase the confidence in their sub-
group analyses by reporting the rationale andmethods in sufficient
detail (Oxman 1992; Rothwell 2005). Measurement of effects on
health inequalities is an active field of research, with over half of
the included studies published in the last two years.
We identified four methods to assess effects on health equity in co-
horts of systematic reviews: 1) describe populations in SRs; 2) de-
scribe populations in primary studies (e.g. randomized controlled
trials or cohort studies); 3) analysis of different effects (benefit or
harm); and 4) applicability assessment. However, the poor avail-
ability of data, both in primary studies and systematic reviews, for
all of these approaches limits their usefulness.
The descriptive and analytic methods used in these methodology
studies (described above) require data on outcomes stratified for
specific populations across PROGRESS-Plus to assess effects in
these populations. However, a lack of population-specific strati-
fied outcome data does not mean that an intervention will not be
effective in other populations (e.g. because primary studies have
not been conducted in these populations or data has not been re-
ported in the primary studies or the systematic reviews). For exam-
ple, vaccination is expected to be effective in diverse populations,
across a range of baseline risk and settings. For interventions tested
in relatively advantaged populations, clinical epidemiology prin-
ciples suggest that the relative risk reduction will remain the same
across differences in baseline risk (Anderson 2005). Thus, the ab-
solute risk reduction is expected to be larger for populations with
a higher baseline risk. For example, therapeutic drug monitoring
was shown to be effective at improving adherence to antiretrovirals
in clinical trials conducted exclusively in high-income countries.
If the relative risk of 1.49 can be applied to low andmiddle income
countries with higher HIV endemicity, a greater absolute effect
may be achieved on population health (Kredo 2009).
None of these 34 empirical studies assessed what factors are as-
sociated with differences in effects on health equity. Identifying
characteristics of interventions, population, comparison, setting,
study design which are associated with effects on health equity
could be used to inform a prioridecisions to assess effects on health
equity in systematic reviews and primary studies.
Descriptive and analytic approaches used by these methodology
studies have the advantage of assessing whether an intervention
has been tested in a specific disadvantaged population, which is
appealing to practitioners and decision-makers deciding whether
to implement an intervention in a specific population and setting.
Analytic approaches have the advantage of providing an estimate
of the magnitude of effect in either advantaged or disadvantaged
populations, or both. However, we found few systematic reviews
which conducted subgroup analyses, and none of them described
the analyses in sufficient detail to assess the credibility of the find-
ings, since they failed to report details on the seven Oxman and
Guyatt credibility criteria (Oxman 1992). Updated guidelines on
subgroup analyses suggest also assessing four more items: 1) con-
sideration of baseline characteristics; 2) independence of the sub-
group effect (i.e. the subgroup effect is not confounded by associ-
ation with another factor); 3) a priori specification of the direction
of effect; and 4) consistency across related outcomes (Sun 2010).
We did not assess these four additional factors.
None of the systematic reviews which reported effects on health
inequalities described whether these different effects were due to
differences in absolute or relative effects. Differences in absolute
effects are expected in groups with a higher baseline risk of the out-
come. For example, women from low and middle income coun-
tries have a higher rate of maternal mortality, and might achieve a
larger benefit in absolute terms from interventions such as having
a skilled attendant at the birth than women in high-income coun-
tries with a very low maternal mortality. Differences in relative
effects suggest that the mechanism of action of an intervention is
different. For example, the relative effect of increases in tobacco
price is greater in low income populations (Thomas 2008).
Judgment of applicability of evidence to disadvantaged popula-
tions and settings makes use of available evidence to inform de-
cisions. Judging applicability or generalizability is used for mak-
ing decisions about populations, interventions, comparisons, out-
comes or settings beyond those studies in the systematic review and
included trials. These methods have the potential to reduce need-
less replication of studies in different populations. Internationally
recognized tools such as SIGN (SIGN 2008) andGRADE (Guyatt
2008, Guyatt 2008a) have the potential to increase the credibility
of these judgments about directness of evidence to specific pop-
ulations, if the judgments about directness are reported transpar-
ently. However, there is limited guidance provided by these tools
on when evidence is sufficiently indirect to warrant downgrad-
ing quality. Applying these checklists is challenging and requires
significant content, methodological and setting-specific expertise
to judge whether: 1) the observed differences is a true differences
or random error; 2) are there differences in absolute effects due
to different prevalence of the condition,or 3) are there differences
in relative effects due to differences in how the intervention is
delivered or received. For example, lack of follow-up in settings
with barriers to accessing regular care could lead to more serious
adverse events if early signs of toxicity are missed. Applying these
checklists is also challenging due to lack of data from settings of
interest, and lack of data on the differences between settings in
the primary studies and the setting to which the results will be ap-
plied. For example, the overviews of interventions to reduce still-
births reported a lack of data from LMIC for most interventions,
and raised questions about the differences in LMIC settings such
as provider skill, availability of emergency transportation and ac-
cess to clean delivery sites (Darmstadt 2009, Haws 2009, Yakoob
2009, Menezes 2009, Bhutta 2009). The reporting of how these
judgments were made was inconsistent.
There is a lack of conceptual clarity regarding the definition of
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health equity. Only three out of 34 studies defined health equity
explicitly. Use of the terms gender and sex in these studies con-
flicted with internationally accepted definitions, i.e. that sex refers
to biological differences and gender refers to cultural and socially
determined roles of males and females (Spitzer 2008).
Six out of 34 studies involved collaboration of the Cochrane Eq-
uity Methods Group. These studies analyzed cohorts of Cochrane
reviews, which may be limited in their ability to detect subgroup
differences since Cochrane reviews tend to contain fewer trials
(median 8 studies) than other systematic reviews (Moher 2007).
Furthermore, Cochrane reviews tend to assess efficacy questions
where the effect size might be less likely to vary in different popu-
lations than for implementation questions which are more likely
to be assessed by pragmatic trials (Thorpe 2009). None of the
methodology studies assessed systematic reviews which focus on
educational, legal and educational interventions; such as those
from the Campbell Collaboration.
We identified six studies which assessed inequalities in health be-
haviours or determinants of health such as tobacco cessation and
uptake of childhood vaccination (Jepson 2010, Bambra 2010,
Main 2008, Ogilvie 2004, Shea 2009, Vergidis 2009). It is well
known that inequalities in health behaviours do not fully explain
inequalities in health status (Marmot 2008). Because the method-
ological challenges of assessing differences in health behaviours
and health outcomes are similar, we included these studies in this
review.
We used a rigorous and transparent process to identify and describe
methods for assessing effects onhealth equity in systematic reviews,
following up to date guidelines from the Cochrane Collaboration
Handbook (Cochrane Handbook 2009). We used a structured
approach to extracting and assessing factors across which health
inequity may exist: the acronym PROGRESS-Plus, accepted by
the Campbell and Cochrane Equity methods group. We used a
team of five people to extract data, and each study was assessed
by at least two review authors. We used the PRISMA reporting
guidelines to facilitate replicability (Moher 2009). There is a risk
that we have missed some relevant studies since methodological
studies of cohorts of systematic reviews are not well-indexed and
also since we decided to apply a geographic filter (Grobler 2008).
We addressed this by using a comprehensive search strategy of both
health and non-health databases, that imposed no limits on study
design based on pilot-testing of the search strategy and review
by a librarian scientist (JM) (Sampson 2008). We also searched
reference lists and used SCOPUS to identify citations of included
studies. Three out of 20 of the included studies were published as
abstracts (Tsikata 2003; Nasser 2007) or reports (Ball 2002) and
one included study was identified by contact with experts (Bambra
2010). Furthermore, one ongoing study and one excluded study
were identified by contacting authors of included studies.
A limitation of this systematic review is that we did not include
individual systematic reviews. We decided a priori that their in-
clusion could lead to bias since they may be less likely to report
analyses of effects on health equity if none were found.
Another limitation of this review is that systematic reviews are de-
pendent on the availability of data in primary studies. This sys-
tematic review did not assess whether data was available in primary
studies nor the different biases which determine the representa-
tion and reporting of different populations and stratified analyses
in primary research. Some of the authors of this review team are
authors on empirical studies included in this review (PT, MP, EK,
EU, VW, JM, GW). We sought to minimize the possible bias of
analysis and synthesis of these studies by having those studies ex-
tracted by a review author who was not a co-author (JdM orMB).
A U T H O R S ’ C O N C L U S I O N S
Implication for systematic reviews and
evaluations of healthcare
There is a need for improved clarity regarding definition of health
equity in systematic reviews which focus on effects of interven-
tions in disadvantaged populations. The final report of theWHO
CSDH (Marmot 2008) provides recommendations on how to as-
sess and define social determinants of health and health equity.
Systematic reviews need to improve reporting of population and
setting characteristics of primary trials in systematic reviews, to
facilitate judgments about applicability, both for disadvantaged
populations, as well as other populations not included in the pri-
mary trials. Regarding subgroup analyses, there is a need to im-
prove the conduct and reporting of subgroup analyses both in
systematic reviews and primary studies to improve their credibil-
ity. These include the need for description of the rationale for
subgroup analyses, assessment of clinical importance of subgroup
differences, description of whether differences between groups are
due to differences in absolute effects or relative effects. Systematic
review authors can consult the Campbell and Cochrane Equity
Methods group for further guidance on analytic approaches to
assessing differences in effects of interventions in disadvantaged
populations. If systematic reviews discuss applicability, they need
to transparently report the details of how these judgments were
made, including who made them (e.g. whether a consensus ap-
proach was used).
Implication for methodological research
Methodological guidance, based on empirical data about the ad-
vantages and disadvantages of different approaches, is needed on
how to assess effects on health equity in systematic reviews.
This systematic review identifies five areas for future research.
Firstly, there is a need for methodological research to identify fac-
tors associated with differences in absolute and relative effects to
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improve our understanding of the rationale for exploring subgroup
effects. Secondly, there is a need for methodological studies to as-
sess the extent to which subgroup analyses can be used to assess in-
tervention-generated inequalities. For example, individual patient
data meta-analysis of individual level factors can be compared with
study-level subgroup analyses to assess consistency of the findings
across and within studies (Sutton 2008). Thirdly, there is a need
for methodological studies to assess differences in absolute and rel-
ative effects between advantaged and disadvantaged populations,
and specifically, how socioeconomic factors may drive the effects
of interventions across groups.. Fourthly, methodological research
onhow tomake judgments about applicability (e.g. to assess effects
of providing structured guidance) on both the replicability of the
judgments as well as their relationship to actual examples of ap-
plying interventions in different populations and settings. Fifthly,
methodological research on how to consider the role of local con-
text at different levels would be useful in considering contextual
factors such as sociopolitical climate when judging applicability.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adamek 2008
Methods Meta-analyses of psychosocial or psychological interventions for older adults (50+)
Data Plus- Age
Comparisons Targeted
Outcomes 16 systematic reviews
Equity definition Equity not defined
Is judgment of equity made, if so, how? Misdiagnosis of older people with depression is described as “needless”
Rationale for assessing PROGRESS-Plus
dimension
Misdiagnosis of mental health and addiction disorders in older people due to discrimi-
nation based on age
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Comprehensive search for reviews focusing
on psychosocial or psychological interven-
tions for people 50 years of age or older
Detection bias? Unclear Methods for extracting details from SRs
were not described
Althabe 2008
Methods To systematically analyse the results of systematic reviews of strategies for improving the
quality of care, where these strategies are relevant to maternal and child health (MCH)
in developing countries
Data Plus-LMIC
Comparisons Targeted
Outcomes 23 systematic reviews
Equity definition Equity not defined, but authors used the SUPPORT equity checklist
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Althabe 2008 (Continued)
Is judgment of equity made, if so, how? Authors judged equality, defined as equitable access to the strategies for the most disad-
vantaged health providers, and for the most vulnerable women and children
Rationale for assessing PROGRESS-Plus
dimension
Need to appraise applicability and relevance of quality improvement strategies in LMIC
to reduce health inequalities in maternal and child health
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes 2 independent reviewers assessed SRs
against explicit inclusion criteria
Detection bias? Yes 2 independent reviewers extracted data us-
ing explicit extraction form
Ball 2002
Methods To review effectiveness of interventions to prevent low birth weight with focus on rele-
vance to socially disadvantaged women
Data SES, race/ethnicity, occupation
Comparisons Targeted
Outcomes 19 systematic reviews
Equity definition Equity not defined
Is judgment of equity made, if so, how? Health inequalities described as deeply entrenched and generational
Rationale for assessing PROGRESS-Plus
dimension
To assess which interventions have the greatest positive impact on prevention of low
birth weight which is concentrated in families living in poverty and deprivation
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Unclear Inclusion criteria not clear - article de-
scribed as review of reviews- papers related
to low birth weight
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Ball 2002 (Continued)
Detection bias? No Nodescription of how articles were selected
Bambra 2010
Methods To identify evidence on interventions to reduce health inequalities by acting on social
determinants of health
Data SES, gender/sex, race/ethnicity, age
Comparisons Gap
Outcomes 30 systematic reviews
Equity definition Health equity not defined
Is judgment of equity made, if so, how? No judgment by authors
Rationale for assessing PROGRESS-Plus
dimension
To identify evidence on interventions to reduce health inequalities by acting on social
determinants of health
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Systematic search of electronic databases +
handsearching
Detection bias? Yes 2 independent reviewers screened titles and
extracted specific data
Barros 2010
Methods Overview of 49 interventions directed towards mothers before and during pregnancy
and childbirth to prevent preterm birth and stillbirth, rated using GRADE criteria for
relevance to LMIC
Data Plus-LMIC
Comparisons Targeted
Outcomes 43 systematic reviews
Equity definition Unacceptable proportion burden of stillbirths in LMIC
Is judgment of equity made, if so, how? Preterm births, stillbirths are avoidable with known interventions
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Barros 2010 (Continued)
Rationale for assessing PROGRESS-Plus
dimension
Highest burden of stillbirth and preterm birth is in LMIC
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Searched electronic databases for meta-
analyses, trials and observational evidence.
Then, interventions included if there was:
1) evidence available, 2) evidence of im-
pact, 3) requires low or no technology, 4)
can be or is used in LMICs and 5) applica-
ble to wide group of pregnant women
Detection bias? Unclear 32 interventions excluded due to: (a) the
available evidence was very limited; (b)
there was no evidence of an impact; (c) the
intervention requires high technology; (d)
the intervention is seldom used; (e) the in-
tervention was applicable to a small sub-
group of pregnant women. Number of sys-
tematic reviews excluded is not reported
Bartels 2003
Methods To assess geriatric-specific evidence-base for mental health care
Data Plus- age and mental health
Comparisons Targeted
Outcomes 23 systematic reviews
Equity definition Equity not defined
Is judgment of equity made, if so, how? Unmet need for age-appropriate evidence-based practice geriatric mental health care
Rationale for assessing PROGRESS-Plus
dimension
Older adults with mental illness receive poorer quality of care (relative to younger people
with mental illness and older people without mental illness) due to likelihood of more
adverse effects and smaller magnitude of benefit for older adults with mental illness
because of cognition, physiological and social functioning changes
Notes
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Bartels 2003 (Continued)
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Systematic search of three electronic
databases, with specific inclusion criteria
(geriatric specific guidelines, evidence re-
views and meta-analyses)
Detection bias? No No description of how data was extracted
or by who
Bhutta 2008
Methods Systematic review of maternal, neonatal, child health interventions with the aim of iden-
tifying a mix of evidence-based interventions and best delivery strategies in developing
countries
Data LMIC
Comparisons Targeted
Outcomes 52 systematic reviews
Equity definition No definition of equity. describe “moral imperative” to achieve MDG 4 and 5 goals on
maternal and child health
Is judgment of equity made, if so, how? No judgment of equity.
Rationale for assessing PROGRESS-Plus
dimension
To deliver on MDGS for maternal and child health
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Unclear Systematic
search of electronic databases, unpublished
reports, UN agencies. Method of selecting
systematic reviews was not described
Detection bias? Yes Data was independently extracted by 3 re-
viewers using pre-designed forms
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Bhutta 2008a
Methods Conducted overview of interventions aim at nutrition outcomes for mothers and chil-
dren, based on meta-analyses where possible
Data LMIC
Comparisons Targeted
Outcomes 26 systematic reviews
Equity definition 160 million (90%) stunted children live in just 36 countries, and make up 46% of
the 348 million children in those countries
Is judgment of equity made, if so, how? No judgment of equity. Authors state “virtually all stunting is avertable”
Rationale for assessing PROGRESS-Plus
dimension
To identify effective interventions and the preventable burden if these interventions were
available in LMIC
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Unclear Systematic search of electronic databases,
screening and selection not described
Detection bias? Unclear Method of extracting data not described
Bhutta 2009
Methods Systematic searches in electronic databases to identify systematic reviews, trials and ob-
servational studies of interventions for delivering interventions to reduce stillbirths by
improving service supply and community demand
Data LMIC
Comparisons Targeted
Outcomes 11 SRs [8 Cochrane, 3 non-Cochrane]
Equity definition Stillbirth rates are higher in LMIC compared to HIC, and these disparities apply within
countries since economically deprived communities have higher stillbirth rates due to
disparities in risk factors and inequalities in access and quality of care. 98% of stillbirths
occur in LMIC
Is judgment of equity made, if so, how? Most stillbirths occur in LMIC and are associated with absent inadequate or delayed
obstetric care, thus they are preventable
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Bhutta 2009 (Continued)
Rationale for assessing PROGRESS-Plus
dimension
In low resource settings, cost, distance and time needed to access care are major barriers
to uptake of antenatal and intrapartum services
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Selected according to specified inclusion
criteria that it reported rate of still births
and was a biologically plausible interven-
tion identified by systematic search of mul-
tiple databases
Detection bias? Unclear Unclear. Method of extracting data and
who performed data extraction was not
provided
Browne 2004
Methods To review effectiveness of interventions to improve mental health for children
Data SES, race/ethnicity, gender/sex, age
Comparisons Targeted
Outcomes 23 systematic reviews
Equity definition Health equity not defined
Is judgment of equity made, if so, how? Absence of resources andopportunities described as risk factor formental health problems
Rationale for assessing PROGRESS-Plus
dimension
Policy initiatives need to be developed to ensure sufficient funding and promote delivery
of effective programs to appropriate children at risk of poor mental health
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes all systematic reviews identified by system-
atic search using predefined inclusion cri-
teria: mental health promotion initiatives
for children
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Browne 2004 (Continued)
Detection bias? Yes used critical appraisal tool to extract data
Chopra 2008
Methods To assess effects of policy options on equitable distribution of health workers in LMIC
Data LMIC
Comparisons Targeted
Outcomes 28 systematic reviews
Equity definition Health equity not defined: lack of health workers in remote/rural areas described as
inequitable
Is judgment of equity made, if so, how? Inequitable distribution of health workers limits quality health care
Rationale for assessing PROGRESS-Plus
dimension
Quality health care depends on sufficient health workers to deliver the care (e.g. in remote
areas), policy makers need evidence on effects of policy options on equitable health care
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes systematic search of electronic databases
with inclusion criteria + handsearching
Detection bias? Yes used structured forms, 2 reviewers ex-
tracted data
D’Souza 2004
Methods To review evidence on improving perinatal outcomes for disadvantaged women
Data SES
Comparisons Targeted
Outcomes 5 systematic reviews
Equity definition Equity not defined
Is judgment of equity made, if so, how? poor health concentrated in low SES women
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D’Souza 2004 (Continued)
Rationale for assessing PROGRESS-Plus
dimension
Poor health outcomes are concentrated in socially disadvantaged mothers
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Systematic search in 8 electronic databases
for systematic reviews and studies on10dif-
ferent subgroups of disadvantaged women
Detection bias? Unclear Methods for data extraction not described
Darmstadt 2005
Methods Systematic review of the evidence on the efficacy and effectiveness of interventions with
the potential to reduce perinatal or neonatal mortality, or both. Our aim was to identify
interventions for use in low-income and middle-income countries- thus high cost tech-
nology interventions were excluded (e.g. ventilation)
Data LMIC
Comparisons Targeted
Outcomes 12 systematic reviews
Equity definition Unacceptably high number of neonatal deaths that happen every year
(4 million), their inequitable distribution, the increasing proportion of child deaths that
take place in the neonatal period, and the importance of reducing neonatal
mortality to meet theMillenniumDevelopment Goal for child survival (MDG-4). Most
neonatal deaths occur at home in low-income and middle-income countries
against a backdrop of poverty, sub-optimum care seeking, and weak health systems
Is judgment of equity made, if so, how? No description of equity. Neonatal deaths are described as avoidable, and disproportion-
ate burden is carried by LMIC
Rationale for assessing PROGRESS-Plus
dimension
Importance of reducing neonatal mortality to meet the MDG-4 for child survival
Notes
Risk of bias
Item Authors’ judgement Description
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Darmstadt 2005 (Continued)
Selection bias? Unclear Searches for systematic reviews, trials
and observational studies in electronic
databases, search terms not provided, se-
lection criteria provided. No description of
who screened the titles or how it was done
Detection bias? Unclear Data extraction methods not described
Darmstadt 2009
Methods Systematic review of the published literature, searching PubMed and the Cochrane
Library, of trials and reviews (N = 230) that reported stillbirth or perinatal mortality
outcomes for eight interventions delivered during labour
Data LMIC
Comparisons Targeted
Outcomes 23 Cochrane reviews
Equity definition Stillbirth rates are higher in LMIC compared to HIC, and these disparities apply within
countries since economically deprived communities have higher stillbirth rates due to
disparities in risk factors and inequalities in access and quality of care. 98% of stillbirths
occur in LMIC
Is judgment of equity made, if so, how? Most stillbirths occur in LMIC and are associated with absent, inadequate or delayed
obstetric care, thus they are preventable
Rationale for assessing PROGRESS-Plus
dimension
Low proportion of stillbirths in HIC suggests they are preventable
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Selected according to specified inclusion
criteria that it report rate of still births
and was a biologically plausible interven-
tion identified by systematic search of mul-
tiple databases
Detection bias? Unclear Method of extracting data and who per-
formed data extraction was not provided
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Doull 2010
Methods Determine whether and how sex and gender are addressed in a sample of Cochrane
systematic reviews in cardiovascular disease
Data Gender and sex based analysis
Comparisons Gap
Outcomes 38 Cochrane SRs
Equity definition not defined
Is judgment of equity made, if so, how? not done
Rationale for assessing PROGRESS-Plus
dimension
Research shows sex and gender are relevant in cardiovascular disease risk factors, but
quality of evidence remains weak for many
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Random sample of 1/3 of reviews from
Cochrane heart, hypertension and periph-
eral vascular disease review groups
Detection bias? Yes Data extracted using pre-tested form by 1
research assistant
Haws 2009
Methods This paper reviews available published evidence for the impact of 14 screening andmoni-
toring interventions in pregnancy on stillbirth, including identification andmanagement
of high-risk pregnancies, advanced monitoring techniques, and monitoring of labour
Data LMIC
Comparisons Targeted
Outcomes 23 SRs (13 Cochrane)
Equity definition Stillbirth rates are higher in LMIC compared to HIC, and these disparities apply within
countries since economically deprived communities have higher stillbirth rates due to
disparities in risk factors and inequalities in access and quality of care. 98% of stillbirths
occur in LMIC
Is judgment of equity made, if so, how? Stillbirths are preventable, and occur in higher rates in economically deprived bothwithin
and between countries
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Haws 2009 (Continued)
Rationale for assessing PROGRESS-Plus
dimension
In order to increase global attention to stillbirths, it is important to assemble a convincing
evidence base for risk factors for stillbirths and for preventive interventions, particularly
in low-income countries
where most stillbirths occur.
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Selected according to specified inclusion
criteria that it report rate of still births
and was a biologically plausible interven-
tion identified by systematic search of mul-
tiple databases
Detection bias? Unclear Method of extracting data and who per-
formed data extraction was not provided
Jepson 2010
Methods Review of reviews to assess effectiveness of behavioural change interventions on health
behaviours and health inequalities. “Subsidiary aim of the review was explore, where
possible, the evidence of impact of interventions on health inequalities”
Data “health inequalities”, no specification of how health inequalities was defined, though
ethnicity, sex, age and socioeconomic status were described in the results
Comparisons Gap
Outcomes 103 systematic reviews
Equity definition Equity not defined. Differences in behaviours, access, recruitment, effectiveness across
socioeconomic status, age, gender, occupations, race/ethnicity were described as impor-
tant for understanding how interventions work in different settings and contexts
Is judgment of equity made, if so, how? No judgment of equity described.
Rationale for assessing PROGRESS-Plus
dimension
Need to take into account the socio-economic and cultural contexts within which people
are located. Also, illness clusters within lower socio-economic groups thus those con-
ducting systematic reviews (as well as those designing interventions) need to make health
inequalities a central concern
Notes
Risk of bias
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Jepson 2010 (Continued)
Item Authors’ judgement Description
Selection bias? Yes Systematic searches in electronic databases,
screened using pre-specified inclusion cri-
teria, independently screened by 2 review-
ers
Detection bias? Unclear Data extraction was by one of 4 reviewers,
and a sample was checked by another re-
viewer
Johnson 2003
Methods To assess whether Cochrane systematic reviews on cardiovascular disease handled gender
differences and whether the data pertaining to treatment of CVD is applicable to the
clinical care of women
Data Gender
Comparisons Gap
Outcomes 31 Cochrane SRs
Equity definition not defined, if study assessed results broken down by gender, then considered gender-
based analysis
Is judgment of equity made, if so, how? Gender-based analysis if: 1) analysis of results broken down by gender; or 2) textual
comparisons of results in men and women
Rationale for assessing PROGRESS-Plus
dimension
Imperative that the practice of medicine be based on high-quality evidence, including
evidence on women. CVD is number one killer of women, yet clinical trials performed
predominantly in men
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Included all completed systematic reviews
in Cochrane Heart group, Hypertension
group, peripheral vascular diseases group.
Detection bias? Unclear Method of extraction not described but de-
tails of data to be extracted were provided
34How effects on health equity are assessed in systematic reviews of interventions (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Jones 2003
Methods Aimed to identify how many child lives could be saved if known effective interventions
were available. Collected evidence on interventions from systematic reviews or random-
ized trials. Assessed relevance to preventing child deaths in LMIC (level 1, 2 or 3) , then
modeled number of lives that could be saved
Data LMIC
Comparisons Targeted
Outcomes 10 systematic reviews (plus other study designs for some interventions)
Equity definition “More than 10 million children dying every year, almost all in low-income countries or
poor
areas of middle-income countries.1 90% of these deaths occurred in just 42 countries,
most from one of a short list of causes: diarrhoea, pneumonia, measles, malaria, HIV/
AIDS, and the underlying cause of undernutrition for deaths among children younger
than 5 years, and asphyxia, preterm delivery, sepsis, and tetanus for deaths among
neonates”
Is judgment of equity made, if so, how? No description of equity judgment.
Rationale for assessing PROGRESS-Plus
dimension
Child deaths in LMIC are preventable with known effective interventions
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Unclear Searches for systematic reviews in Medline
and Popline, search terms not provided.
Screening and selection methods were not
described
Detection bias? Unclear Methods of data extraction not described
Lewin 2008
Methods To summarize evidence from systematic reviews that have the potential to improve
delivery of cost-effective interventions in primary health care in LMIC
Data LMIC
Comparisons Targeted
Outcomes 20 Systematic reviews
Equity definition Health equity not defined, mention equitable distribution of health services
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Lewin 2008 (Continued)
Is judgment of equity made, if so, how? Inadequate delivery of cost-effective interventions is both unfair and avoidable
Rationale for assessing PROGRESS-Plus
dimension
To reach AlmaAta goal of health for all, need to assess which health systems interventions
are applicable and relevant in LMIC
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes systematic search with prespecified inclu-
sion criteria,
Detection bias? Yes 2 independent reviewers screened for inclu-
sion and extracted data and assessed quality
using forms
Main 2008
Methods To review effectiveness of population-level tobacco control interventions to reduce social
inequalities
Data SES
Comparisons Gap
Outcomes 19 systematic reviews
Equity definition Authors mention applying an equity lens
Is judgment of equity made, if so, how? equity lens to assess whether systematic reviews can be used to answer questions about
reducing health inequalities across SES, ethnicity education
Rationale for assessing PROGRESS-Plus
dimension
Reducing social inequalities in smoking and its health consequences is a public health
priority
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Pre-defined inclusion criteria to identify
all SRs with details on sociodemographic
characteristics of participants
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Main 2008 (Continued)
Detection bias? Yes 2 independent reviewers screened abstracts,
extracted data and assessed quality
Menezes 2009
Methods Systematic review of the evidence for 16 antenatal interventions with the potential to
prevent stillbirths. We searched a range of sources including PubMed and the Cochrane
Library. For interventions with prior Cochrane reviews, we conducted additional meta-
analyses including eligible newer randomised controlled trials following the Cochrane
protocol.We focused on interventions deliverable at the community level in low-/middle-
income countries, where the burden of stillbirths is greatest
Data LMIC
Comparisons Targeted
Outcomes 31 SRs [25 Cochrane reviews, 6 non-Cochrane SRs]
Equity definition Stillbirth rates are higher in LMIC compared to HIC, and these disparities apply within
countries since economically deprived communities have higher stillbirth rates due to
disparities in risk factors and inequalities in access and quality of care. 98% of stillbirths
occur in LMIC
Is judgment of equity made, if so, how? Potentially preventable or treatable by treating infections and maternal conditions such
as diabetes
Rationale for assessing PROGRESS-Plus
dimension
Interventions targeting risk factors may reduce stillbirths, especially in LMIC
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Selected according to specified inclusion
criteria that it report rate of still births
and was a biologically plausible interven-
tion identified by systematic search of mul-
tiple databases
Detection bias? Unclear Method of extracting data and who per-
formed data extraction was not provided
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Morrison 2004
Methods To compile quantitative reviews of studies of adherence; to critique this literature and
summarize current knowledge of adherence
Data Gender/sex, SES and age
Comparisons Gradient
Outcomes 12 SRs, MAs or quantitative overviews
Equity definition not defined
Is judgment of equity made, if so, how? not done
Rationale for assessing PROGRESS-Plus
dimension
SES, gender and age assessed as potential effect modifiers for interventions aimed at
increasing adherence
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Any SR, MA or quantitative overview that
assessed adherence with prescribed medi-
cations; aimed at patients; more than 1 in-
cluded study
Detection bias? Unclear Data extraction not described
Nasser 2007
Methods To identify Cochrane reviews that are relevant to developing countries; and to determine
how they tackled the developing country setting
Data Place of residence, SES, LMIC
Comparisons Gap
Outcomes 420 Cochrane SRs
Equity definition Not defined nor discussed
Is judgment of equity made, if so, how? Not done
Rationale for assessing PROGRESS-Plus
dimension
Different prevalence in LMIC; cost-effectiveness more important in LMIC, challenges
in implementation may be different in LMIC than HIC
Notes
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Nasser 2007 (Continued)
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes all SRs that mentioned LMIC in title, ab-
stract or text were included
Detection bias? No methods for data extraction not described
Odierna 2009
Methods To assess racial/ethnic, gender, and socioeconomic status (SES) concordance between
Medicaid populations and studies synthesized in Drug Effectiveness Review Project
(DERP) systematic reviews
Data SES, race/ethnicity
Comparisons Gap
Outcomes 32 systematic reviews
Equity definition Health equity defined as eliminating avoidable inequalities, particularly those that result
from injustice or social exclusion
Is judgment of equity made, if so, how? Health equity requires improving health outcomes for all sectors of the population, not
benefitting only the advantaged
Rationale for assessing PROGRESS-Plus
dimension
Health policies need to be evaluated to ensure that they are not unintentionally increasing
health inequalities
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes All drug effectiveness reviews from 2004-
2007 were included
Detection bias? Yes One reviewer extracted data, and this was
verified by a second reviewer
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Ogilvie 2004
Methods To assess the potential contribution of evidence from existing systematic reviews of
effectiveness to answering the question: what works in reducing social inequalities in
smoking?
Data ”any socio-demographic variable“, not further defined, but later mentions age, sex and
SES
Comparisons Gap
Outcomes 6 Cochrane SRs
Equity definition Not defined, review intends to assess ”social distribution of intervention effects“, ”social
inclusiveness or targeting of interventions
Is judgment of equity made, if so, how? No judgment on fairness, all inequalities across social dimensions are assessed
Rationale for assessing PROGRESS-Plus
dimension
Reducing social inequalities in a political priority- is evidence available that tobacco
control policies will help achieve this?
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes All completed reviews of the effectiveness
of community-base tobacco control inter-
ventions
Detection bias? Unclear Data extraction methods not described but
data to be collected were described
Shea 2009
Methods Overview of 4 SRs on increasing demand for childhood vaccinations in LMIC
Data LMIC
Comparisons Targeted
Outcomes 4 systematic reviews
Equity definition Not defined.
Is judgment of equity made, if so, how? No judgment of equity
Rationale for assessing PROGRESS-Plus
dimension
Importance of problem of how to increase childhood vaccination in developing countries
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Shea 2009 (Continued)
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Systematic search, with inclusion criteria, a
priori protocol, screening by 2 reviewers
Detection bias? Unclear Method of data extraction not reported
Sherr 2009
Methods Conducted gender analysis on 6 SRs related to children and HIV: 1) Hiv treatment
resistance, 2) adherence to treatment, 3) HIV and schooling, 4) HIV and nutrition, 5)
HIV and cognitive development, 6) HIV and bereavement
Data Gender/sex
Comparisons Targeted and gap
Outcomes 6 systematic reviews (2 Cochrane and 4 were conducted as part of this study)
Equity definition Social and cultural aspects of gender which disadvanatge or disempower subgroups,
gender discrimination
Is judgment of equity made, if so, how? gender affects the biological susceptibility to IV/AIDS as well as the social susceptibility
through gender roles, gender differences and gender responses, including gender discrim-
ination. Social and cultural constructs of gender disadvantage or disempower subgroups,
violence, sexual attitudes
Rationale for assessing PROGRESS-Plus
dimension
gender affects the biological susceptibility to IV/AIDS as well as the social susceptibility
through gender roles, gender differences and gender responses, including gender discrim-
ination. Social and cultural constructs of gender disadvantage or disempower subgroups,
violence, sexual attitudes
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Unclear For two topics, SRs existed, for 4 topics,
they conducted a SR. A priori protocol,
double extraction and screening were not
mentioned
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Sherr 2009 (Continued)
Detection bias? Unclear Methods for extracting data were not de-
scribed. Eg no description of who extracted
the data or whether they used a pre-deter-
mined extraction form
Stewart 2006
Methods What factors help or hinder the process of transition to adulthood for youth with dis-
abilities? What service delivery methods have been used?
Data Plus- youth with disabilities
Comparisons Targeted
Outcomes 5 systematic reviews
Equity definition Equity not defined
Is judgment of equity made, if so, how? Authors describe worse outcomes in youth with disabilities than their peers
Rationale for assessing PROGRESS-Plus
dimension
Youth with disabilities do not have same outcomes as peers for health, achievement and
employment
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Pre-specified inclusion criteria to identify
systematic reviews
Detection bias? Yes Risk of bias: extracted details using Critical
Appraisal Skills Program
Tsikata 2003
Methods To determine whether Cochrane reviews report and analyze the data needed to assess the
effectiveness of interventions at reducing health inequities
Data PROGRESS-Plus
Comparisons Gap
Outcomes 95 Cochrane SRs
Equity definition Health inequities defined as avoidable and unfair inequalities in health, across SES
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Tsikata 2003 (Continued)
Is judgment of equity made, if so, how? All inequalities across PROGRESS were assessed
Rationale for assessing PROGRESS-Plus
dimension
Need for evidence on what works to reduce inequalities across socioeconomic strata
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Random sample of 10% of systematic re-
views published between issue 1, 2000 to is-
sue 2, 2003 in theCochrane Library; strati-
fied by review group (n=42; 7 Cochrane re-
view groups excluded because <5 reviews)
Detection bias? Yes Data extraction was done by 2 reviewers,
using a pre-tested form; discrepancies re-
solved by discussion
Tugwell 2008
Methods To apply the “equity lens” to Cochrane reviews of rheumatoid arthritis
Data PROGRESS
Comparisons Gap
Outcomes 14 Cochrane SRs
Equity definition Health equity defined as: 1) effective in people who are disadvantaged or;
Is judgment of equity made, if so, how? fairness and avoidability referenced, but not judged by authors
Rationale for assessing PROGRESS-Plus
dimension
Need for evidence on what works to reduce inequalities across socioeconomic strata
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes All systematic reviews of the musculoskele-
tal review group published since Issue 1,
2003
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Tugwell 2008 (Continued)
Detection bias? Yes Double extraction by 2 reviewers with pre-
tested form
Vergidis 2009
Methods Identified 18 meta-analyses of interventions specifically focused at populations that are
at high risk for high risk behaviour: minority populations (Latinos, African/Americans)
, men who have sex with men, injection drug users and people living with HIV
Data Race/ethnicity [minority populations], “Plus”: [men who have sex with men, injection
drug users, people living with HIV]
Comparisons Targeted
Outcomes 18 systematic reviews
Equity definition Not defined.
Is judgment of equity made, if so, how? No judgment of equity
Rationale for assessing PROGRESS-Plus
dimension
Behavioural interventions are aimed at specific populations
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? No Method of identifying meta-analyses was
not reported.
Detection bias? No Methods for data extraction were not re-
ported
Viswanathan 2008
Methods To summarize maternal health research priorities, map these priorities to existing reviews,
identify gaps that can be addressed with systematic reviews, including racial disparities
Data Race, ethnicity
Comparisons Gap
Outcomes 64 systematic reviews
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Viswanathan 2008 (Continued)
Equity definition Equity not defined.
Is judgment of equity made, if so, how? Disparities in health outcomes remain after adjusting for medical risk
Rationale for assessing PROGRESS-Plus
dimension
Persistent disparity in health outcomes by race suggests a role for further research on
interventions that narrow the gap
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Search of medline using MESH delivery,
obstetric, systematic reviews, relevant to
MCH
Detection bias? Unclear Authors state ”each study was reviewed to
establish nature of intervention, primary
outcome and subanalysis of racial dispari-
ties
Yakoob 2009
Methods Systematic overview of systematic reviews, primary studies on covers 12 different inter-
ventions relating to behavioural and socially mediated risk factors, including exposures
to harmful practices and substances, antenatal care utilisation and quality, and maternal
nutrition before and during pregnancy
Data LMIC
Comparisons Targeted
Outcomes 14 Cochrane, 2 non-Cochrane= 16 SRs
Equity definition from overview paper {9074}, stillbirth rates are higher in LMIC compared to HIC, and
these disparities apply within countries since economically deprived communities have
higher stillbirth rates due to disparities in risk factors and inequalities in access and
quality of care. 98% of stillbirths occur in LMIC
Is judgment of equity made, if so, how? Many stillbirths are preventable by access to antenatal care and obstetric care, and by
reducing risk factors
Rationale for assessing PROGRESS-Plus
dimension
In order to increase global attention to stillbirths, it is important to assemble a convincing
evidence base for risk factors for stillbirths and for preventive
interventions, particularly in low-income countries
where most stillbirths occur.
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Yakoob 2009 (Continued)
Notes
Risk of bias
Item Authors’ judgement Description
Selection bias? Yes Selected according to specified inclusion
criteria that it report rate of still births
and was a biologically plausible interven-
tion identified by systematic search of mul-
tiple databases
Detection bias? Unclear Method of extracting data and who per-
formed data extraction was not provided
PROGRESS-Plus: Place of residence (urban/rural), Race/ethnicity, Occupation, Gender, Religion, Education, Socioeconomic status
and Social Capital; “Plus” captures other factors which are associated with decreased opportunity for good health such as disability,
sexual preference, disease status or resource-poor settings; SR: Systematic Review; LMIC: Low and Middle Income Countries; HIC:
High income countries; MA: meta-analysis; SES: socioeconomic status
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ahmad 2010 Assessed reporting of sex, age and race in a cohort of 98 SRs on tobacco control and HIV. No assessment
of differences in health outcomes across these characteristics
AHRQ 2010 No assessment of effects on health equity or health inequalities. A cohort of systematic reviews was eval-
uated to assess how clinical heterogeneity was assessed, including whether population characteristics are
prespecified for subgroup analyses
Barlow 2004 No focus on health equity. Assessed effects of interventions for children with chronic disease using SRs but
made no judgment that these children were disadvantaged or that these interventions could affect health
inequalities or health inequities
Craig 2003 No focus on health equity. Assessment of effects of treatments for sexual offenders from SRs
Espinosa-Aguilar 2007 No focus on health equity. 8 SRs were included on effects of interventions in the elderly, with no focus on
equity, inequalities or disadvantage
Gaes 1999 No focus on health equity. Assesses effectiveness of correctional rehabilitation using SRs
Gulmezoglu 1997 No focus on health equity. Assessed effects of interventions to prevent impaired fetal growth
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(Continued)
Thomas 2008 Not a cohort of systematic reviews. This is a single systematic review of tobacco control interventions
Characteristics of ongoing studies [ordered by study ID]
Panteli 2009
Trial name or title Equity and Health technology assessment
Methods systematic review of equity considerations in HTA
Data HTA reports
Comparisons Equity issues were classified according to HTA core domains
Outcomes
Starting date 2009
Contact information dpanteli@mailbox.tu-berlin.de
Notes
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Selected methods of assessing effects on health inequalities
Method Calculation
Targeted approach Evaluation of effect size in the disadvantaged population only (e.g. Cochrane Review on com-
munity animal health services for improving household wealth and health status of low income
farmers by Curran 2006).
Relative difference (gap approach) (advantaged - disadvantaged)/advantaged
Absolute difference (gap approach) advantaged - disadvantaged
Gradient-approach regression Regression-based index of relative effect across incremental categories of disadvantage
Gradient-concentration index Twice the area between the concentration curve and the line of equality (45 degrees line),
defined with reference to the concentration curve, which graphs health status on the y-axis
against categories of disadvantage on the x-axis (World Bank).
Gradient or gap-benefit incidence Computes the distribution of public expenditure across different PROGRESS-Plus groups
according to actual utilization of services
Gradient approach - Gini index Measure of inequality of income distribution, defined as the area between the line of equality
and the Lorenz curve, with categories of PROGRESS on the x-axis and percentage of total
income on the y-axis (Gastwirth 1972).
PROGRESS-Plus: Place of residence (urban/rural), Race/ethnicity, Occupation, Gender, Religion, Education, Socioeconomic status,
and Social capital. “Plus” includes any other factors that are associated with decreased opportunities for good health such as age,
disability, disease status or sexual preference.
Table 2. Methods used to assess whether health equity was considered in systematic reviews
Methods used to assess
health equity effects
Which studies used this
method
Data availability Advantages Disadvantages
1a. De-
scriptive- SRs mention
PROGRESS-Plus
Doull 2010, Nasser
2007, Lewin 2008; Sherr
2009
Gender/sex (15/44 SRs)
, LMIC (6/20 SRs)
Indicates whether au-
thors of systematic re-
views have considered
health equity
Does not assess effects on
health equity or health
inequalities
1b. Descriptive- SRs de-
scribe population across
PROGRESS-Plus factor
(s)
Nasser 2007, Doull
2010, Tugwell 2008,
Ogilvie 2004, Tsikata
2003, Lewin 2008; Sherr
2 studies did not re-
port data availability (
Nasser 2007; Ogilvie
2004); For the other
Provides direct data on
whether different popu-
lations included in SRs
Does not analyze influ-
ence of population char-
acteristics or setting on
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Table 2. Methods used to assess whether health equity was considered in systematic reviews (Continued)
2009; Yakoob 2009;
Haws 2009; Darmstadt
2009; Bhutta 2009;
Menezes 2009
3 studies, PROGRESS-
Plus data was available
for: Place of residence
(5/95 SRs); race/ethnic-
ity (7/95 SRs); occupa-
tion (1/95 SRs); gender/
sex (90/153 SRs); reli-
gion (1/95 SRs); educa-
tion (0/95 SRs); SES (4/
95SRs); social capital (0/
95 SRs), LMIC (13/58
SRs reported >1 study in
LMIC)
which is useful for judg-
ing applicability
effects on health inequal-
ities
Data available for gender
in 57% of SRs, others
are available in less than
25% of SRs
1c. Descriptive- SR de-
scribes if intervention is
given only to disadvan-
taged populations across
PROGRESS-Plus
Nasser 2007, Ogilvie
2004, Tsikata 2003;
Main 2008, Adamek
2008, Stewart 2006,
D’Souza 2004, Ball
2002, Browne 2004;
Tugwell 2008; Bartels
2003,
Bhutta 2008, Shea 2009,
Jones 2003, Darmstadt
2005, Vergidis 2009,
Bhutta 2009, Darmstadt
2009, Haws 2009,
Menezes 2009, Sherr
2009, Yakoob 2009
Data not reported for 2
studies (Ogilvie 2004),
(Nasser 2007); 17/114
SRs described interven-
tions aimed at people de-
fined by race/ethnicity,
gender/sex, low SES or
age (Tsikata 2003;Main
2008); seven methodol-
ogy studies selected only
SRs that focused on dis-
ad-
vantaged groups across
PROGRESS; 100/
217 SRs included studies
conducted in LMICs
Three
overviews described that
some systematic reviews
were
conducted in LMIC, but
did not report details for
all SRs
Assesses if interventions
have been tested in spe-
cific disadvantaged pop-
ulations
Does not assess effects of
intervention
Can be misleading since
SRs with no studies con-
ducted in disadvantaged
populations may still be
relevant and applicable
1d. Descriptive- Out-
comes of SR related to
equity of access
Tsikata 2003, Nasser
2007, Althabe 2008,
Lewin 2008, Bambra
2010, Chopra 2008,
Jepson 2010
Equity of access mea-
sured in 18/173 SRs.
Data not reported by
one study (Nasser 2007)
. One overview reported
that no SRs had details
about equity of access (
Jepson 2010)
Provides data on access
to health care, a determi-
nant of health inequali-
ties
Data on access to care
does not measure effects
on health inequalities
Measuring ac-
cess to health care is de-
pendent on the question
and availability of data
depends on selection cri-
teria of methodology re-
view
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Table 2. Methods used to assess whether health equity was considered in systematic reviews (Continued)
1e. Descriptive- describe
if SRs conduct or plan
subgroup analyses across
PROGRESS-Plus
Tugwell 2008; Ogilvie
2004; Johnson 2003;
Tsikata 2003,
Viswanathan 2008,
Main 2008, Lewin 2008,
Odierna 2009, Bambra
2010; Sherr 2009
Analy-
sis by PROGRESS-Plus
subgroup in 22/198 SRs;
Place of residence; 0;
Race/ethnicity (12/262)
; Occupation (0); Gen-
der 19/204; Religion (0)
; Education (0); SES (1/
198); 6/49SRs assess dif-
ferences across SES, gen-
der or race
Subgroup analysis pro-
vides direct data needed
to answer whether the
intervention works the
same or differently in
populations of interest
Lack of data: data avail-
able by PROGRESS-
Plus subgroups of inter-
est in 10% of SRs (28/
247 had data)
2a. Descriptive- assess
if primary studies de-
scribe population across
PROGRESS-Plus
Tugwell 2008; Tsikata
2003, Johnson 2003,
Ogilvie 2004 for 1 SR;
Sherr 2009, Vergidis
2009, Bhutta 2009,
Darmstadt 2009, Haws
2009, Menezes 2009,
Yakoob 2009
Place of residence (26/
263), race/ethnicity (42/
263), occupation (24/
250), gender/sex (260/
350), religion (0), educa-
tion (42/263), SES (25/
263), Social capital (24/
250)
227/836 RCTs
conducted in LMIC
Provides evidence on
whether sufficient evi-
dence is available from
primary studies to con-
duct subgroup analyses
in SRs
Data may not
be available stratified by
PROGRESS-Plus fac-
tors in the primary stud-
ies
2b. Descriptive- assess if
primary
studies stratified analyses
by PROGRESS-Plus
Tugwell 2008; Ogilvie
2004, Johnson 2003,
Tsikata 2003; Sherr
2009, Jepson 2010
11 of 147 primary
studies stratified by one
or more PROGRESS-
Plus (Tugwell 2008);
96/366 assessed gender/
sex (Johnson 2003; Sherr
2009); 10/76 and 5/14
stratified by sex (Ogilvie
2004); 7/103 stratified
by education, sex or SES
(Tsikata 2003).
In Sherr 2009; SRs were
classified according to
whether there was posi-
tive, negative or no effect
of gender [32/108 RCTs
analyzed effects by gen-
der (sic)]
In Jepson 2010, 2/103
SRs were described as as-
sessing “effect modifiers”
such as sex, age, ethnicity
and socioeconomic sta-
tus
Identifies whether sub-
group analyses
across PROGRESS-Plus
are available in primary
studies and the direction
and magnitude of effects
in different populations
Time-consuming to as-
sess all primary studies of
included SRs
Does not rule out the
possibility of spurious
statistical significance
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Table 2. Methods used to assess whether health equity was considered in systematic reviews (Continued)
3a. Analytic: association Morrison 2004, Sherr
2009
Age in 8/12 SRs; Sex in
7/12 SRs; SES in 5/12
SRs.
In one overview, gender
analysis was conducted
and the effect of gender
was assessed as positive,
negative or no effect on
results (Sherr 2009)
Indicates whether
PROGRESS-Plus fac-
tors are associated with
different relative effects
Could be used to as-
sess gradients of effect
modification according
to different levels of
PROGRESS-Plus (e.g.
poverty)
Data unavailable for
33% of SRs (4/12)
3b. Analytic: rela-
tive comparison of effect
size in two groups using
an odds ratio
None
3c. Analytic: assess ef-
fects in a disadvantaged
population
Adamek 2008, Stewart
2006, D’Souza 2004,
Ball 2002, Browne 2004;
Bartels 2003, Vergidis
2009, Jepson 2010
Identified median of 11
SRs with targeted evi-
dence (range 5-23); three
studies reportedmedium
to large effect sizes of
interventions targeted at
depression in older
adults (Adamek 2008)
, youth with disabili-
ties (D’Souza 2004) and
mental health promo-
tion in children (Browne
2004). One study re-
ported effect sizes for
specific populations: mi-
nority populations, men
who have sex with men,
injection drug users and
people with HIV, and re-
ported a synthesized ef-
fect size of 1.34 (95%
confidence interval of 1.
13 to 1.64) (Vergidis
2009). Three studies did
not report effect sizes
Directly applicable for
decisions about inter-
ventions in these spe-
cific disadvantaged pop-
ulations
Identifies evidence gaps
Lack of data in some dis-
advantaged populations
limits the use of this ap-
proach for other popula-
tions and settings
Low methodological
quality of SRs may limit
applicability
Lack of data on process
of implementation
4a. Applicability: assess
likely impact on disad-
vantagedpopulations us-
ing checklists for appli-
cability and equity
Althabe 2008, Lewin
2008, Chopra 2008,
Barros 2010, Darmstadt
2005, Jones
2003, Bhutta 2009,
Darmstadt 2009, Haws
8/20 SRs were consid-
ered most transferable to
LMIC setting (Lewin
2008), 1 study only in-
cluded SRs if they were
deemed applicable in
Useful summary for pol-
icy-makers about likely
relevance in LMIC set-
tings
Standardized
Does not assess the mag-
nitude of effect in differ-
ent populations
Requires con-
tent and methodological
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Table 2. Methods used to assess whether health equity was considered in systematic reviews (Continued)
2009, Menezes 2009,
Yakoob 2009
LMIC settings (Althabe
2008), 1 study assessed
applicability to LMIC
settings using the SUP-
PORT checklist
GRADE was used to
assessed quality of evi-
dence which includes an
assessment of directness
to the population of in-
terest (LMIC in these
studies) in three stud-
ies (Barros 2010, Bhutta
2008, Lewin 2008).
Two studies used criteria
of biological plausibility,
impact and feasibility in
LMIC (see Appendix 7)
(Jones 2003, Darmstadt
2005)
Five studies used the
SIGN tools which as-
sess directness, and also
considered the feasibil-
ity and potential im-
pact of these interven-
tions in resource poor
settings (Bhutta 2009,
Darmstadt 2009, Haws
2009, Menezes 2009,
Yakoob 2009)
format makes judgments
explicit and transparent
Does not require replica-
tion of studies in differ-
ent populations and set-
tings
Not subject to statistical
power issues of subgroup
analyses
expertise to make equity
and applicability judg-
ments
Low availability of data
to make judgments (
Althabe 2008), (Lewin
2008), (Chopra 2008)
SES: Socioeconomic status; PROGRESS: PROGRESS: Place of residence (urban/rural), Race/ethnicity, Occupation, Gender, Religion,
Education, Socioeconomic status and Social Capital
Table 3. Subgroup analyses: assessment against credibility criteria
Johnson
2003
Tsikata
2003
Ogilvie
2004
Odierna
2009
Lewin
2008
Tugwell
2008
Viswanathan
2008
Main
2008
Bambra
2010
Sherr
2009
Jepson
2010
Clini-
cally im-
por-
tant dif-
ference
Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
Yes, dif-
ferences
in ef-
fect that
could af-
fect
health
No SRs
(0/
14) con-
ducted
sub-
group
analyses
No SRs
(0/
64) con-
ducted
sub-
group
Can’t
tell- 3/
19 SRs
assessed
ef-
fects on
Can’t
tell- 8/
30 SRs
assessed
ef-
fects on
not de-
scribed
Not de-
scribed
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Table 3. Subgroup analyses: assessment against credibility criteria (Continued)
equity in
4/20
SRs
analy-
sis across
race
health
inequal-
ities
health
inequal-
ities
Statisti-
cally sig-
nifi-
cant dif-
ference
Not de-
scribed,
state
“poten-
tial dif-
fer-
ence” in
3 out of
31 sys-
tematic
reviews
Yes, in 1/
95SRs
Not de-
scribed
Yes, 5/
16 SRs
reported
statisti-
cally sig-
nifi-
cant dif-
ference
in effects
across
gender
or race
Not de-
scribed
No data No data Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
A priori
hypoth-
esis
Not de-
scribed
Yes Yes Not de-
scribed
Not de-
scribed
No data No data yes yes Not de-
scribed
Not de-
scribed
One of a
small
number
of hy-
potheses
tested
Not de-
scribed
Yes Not de-
scribed
Not de-
scribed
Not de-
scribed
No data No data Not de-
scribed
Not de-
scribed
y Not de-
scribed
Differ-
ences
sug-
gested
by
within
study
compar-
isons
Not de-
scribed
Yes Not de-
scribed
Not de-
scribed
Not de-
scribed
No data No data Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
Differ-
ence
consis-
tent
across
studies
Not de-
scribed
NA-
only 1
study
Not de-
scribed
Not de-
scribed
Not de-
scribed
No data No data Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
Indi-
rect evi-
dence to
sup-
port hy-
Yes,
evidence
that
cardio-
vascular
yes- eco-
nomic
ratio-
nale why
trans-
Yes,
smoking
is associ-
ated
with so-
Not de-
scribed
Not de-
scribed
No data No data Yes Yes Yes Yes
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Table 3. Subgroup analyses: assessment against credibility criteria (Continued)
pothesis risk
factors,
presen-
tation,
treat-
ment
and
treat-
ment
out-
comes
vary
between
men and
women
port in-
centives
would
work
better
for
poorer
people
cial dis-
advan-
tage
Statis-
tical sub-
group by
treat-
ment in-
terac-
tion
Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
No data No data Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
Primary
stud-
ies strati-
fied ran-
domiza-
tion
by sub-
group of
interest
Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
No data No data Not de-
scribed
Not de-
scribed
Not de-
scribed
Not de-
scribed
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
The search terms for MEDLINE are listed below, along with the number of hits obtained from searching MEDLINE from January
1960 to January week 2, 2009. The search strategy will be adapted for the other electronic databases.
1 exp Meta-Analysis as Topic/ 8694
2 systematic review.tw. 13239
3 meta-analys$.tw. 21728
4 meta-epidemiolog$.tw. 10
5 exp “Review Literature as Topic”/ 3979
6 (Cochrane adj2 review).tw. 967
7 OR/1-6 39977
8 (gender-based OR gender-related OR gender differences OR gender factors).mp. 12856
9 ((sex OR gender) adj2 (analysis OR specific OR difference? OR factor? OR inequit$ OR disparit$ OR inequalit$)).mp. 196205
10 exp sex factors/ 164145
11 exp geriatrics/ 23034
12 ((ethnic$ OR race OR racial OR religio$ OR cultur$ OR minorit$ OR refugee OR indigenous OR aboriginal) adj3 (analysis OR
difference$ OR specific OR disparit$ OR inequalit$ OR inequit$)).tw. 26985
13 exp homosexuality/ 16581
14 exp disabled persons/ 35507
15 ((poverty OR low-income OR socioeconomic$ OR social) adj2 (analysis OR disadvantage$ OR specific OR difference? OR factor?
OR inequalit$ OR depriv$ OR inequit$ OR disparit$)).mp. 87592
16 exp Educational Status/ 26647
17 exp Socioeconomic Factors/ 248934
18 ((discriminat$ OR social exclu$ OR social inclu$) adj3 (religion OR culture OR race OR racial OR aboriginal OR indigenous OR
ethnic$)).tw. 475
19 ((urbanOR rural OR inner-city OR slum) adj2 (difference$OR specificOR analysis OR inequit$ OR disparit$ OR inequalit$)).tw.
1464
20 ((resource-poor OR (low-income adj countr$) OR (middle income adj countr$) OR africa OR developing countr$ OR south
america OR china OR asia OR latin america) adj2 (relevance OR analysis OR specific OR difference OR applicab$ OR inequit$ OR
disparit$ OR inequalit$)).tw. 541
21 OR/8-20 522320
22 7 AND 21 1672
Appendix 2. Search strategies in other databases
CINAHL 1998 to Jan 28 2009 = 608 results:
TX ( meta-analysis OR systematic review OR meta-epidemiolog* ) and ( TX sex OR gender OR race OR ethnic OR indigenous OR
socioeconomic OR elderly OR homosexual OR urban OR rural OR aboriginal OR slum OR developing country OR refugee OR
poverty OR education ) and ( subgroup analysis OR sensitivity analysis OR specific OR equity OR disparity OR inequality )
Index to foreign legal periodicals
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1 ((meta-analysis or system-
atic review or meta-epidemi-
olog$) and (sex or gender or
race or ethnic or indigenous
or socioeconomic or elderly
or homosexual or urbanor ru-
ral or aboriginal or slum or
developing country or refugee
or poverty or education) and
(subgroup analysis or sensitiv-
ity analysis or specific or eq-
uity or disparity or inequality)
).mp
0 Advanced -
2 meta-analysis.tw. 0 Advanced -
3 systematic review.tw. 8 Advanced DISPLAY
4 meta-synthesis.tw. 0 Advanced -
5 meta-analysis.mp. 0 Advanced -
6 synthesis.mp. 17 Advanced DISPLAY
7 or/1-6 25 Advanced DISPLAY
ERIC- Jan 28, 2009- 90 records
((meta-analysis or (“systematic review”) ormeta-epidemiol$) or DE=meta-analysis) and(((gender-based or sex-based) and KW=((gender
or sex) and (based or specific or difference))) or((educational AND (status OR attainment)) WITHIN 2 (specific or difference* OR
disparit* OR inequalit* OR (subgroup analysis) OR inequit*)) or((poverty OR low-income OR socioeconomic* OR social) WITHIN
2 (specific or difference* OR disparit* OR inequalit* OR (subgroup analysis) OR inequit*)) or((geriatric OR elderly) WITHIN 2
((subgroup analysis) OR difference* OR disparit* OR inequit* OR inequalit* OR specific)) or(“developing nations” WITHIN 2
(difference* OR specific OR (subgroup analysis) OR inequit* OR inequalit*)) or((urban OR rural OR inner-city OR slum) WITHIN
2 (specific or difference* OR disparit* OR inequalit* OR (subgroup analysis) OR inequit*)) or((ethnic* OR minorit* OR racial OR
cultur* OR aboriginal OR religio* OR indigenous OR refugee) WITHIN 2 (specific or difference* OR disparit* OR inequalit* OR
(subgroup analysis) OR inequit*)) or(disabilit* WITHIN 2 (specific OR difference OR inequit* OR inequal* OR “subgroup analysis”
OR discriminat*)))
Education abstracts- Jan 28, 2009, 176 records
Search Query #20 ((meta-analys* or (systematic review) or meta-epidemiol*) or meta-synthes*) and ((religio* or cultur*) or
((education status) or (education attainment) or literacy) or ((socioeconomic status) or poverty or low-income) or ((developing
countries) or africa or (ChinaOR South AmericaOR AsiaOR Eastern Europe)) or (homosexual or lesbian) or(elderly or geriatr*)
or (gender or sex) or ((urban or rural or (inner-city OR slum)) or (race or ethnic* or (aboriginal OR indigenous OR refugee)) or
(occupation or blue-collar))) (Copy Query)
PAIS 1983 to jan 28, 2009, 18 records
(((meta-analys* or (systematic review) or meta-epidemiol*) or meta-synthes*) and ((religio* or cultur*) or ((education status) or
(education attainment) or literacy) or ((socioeconomic status) or poverty or low-income) or ((developing countries) or africa or (China
OR South America OR Asia OR Eastern Europe)) or (homosexual or lesbian) or(elderly or geriatr*) or (gender or sex) or ((urban
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or rural or (inner-city OR slum)) or (race or ethnic* or (aboriginal OR indigenous OR refugee)) or (occupation or blue-collar))))
and((specific or subgroup or sensitivity) or ((equit* OR inequit*) or disparit* or inequalit*) or (factor or difference))
social services abstracts, 545 records
(((meta-analys* or (systematic review) or meta-epidemiol*) or meta-synthes*) and ((religio* or cultur*) or ((education status) or
(education attainment) or literacy) or ((socioeconomic status) or poverty or low-income) or ((developing countries) or africa or (China
OR South America OR Asia OR Eastern Europe)) or (homosexual or lesbian) or(elderly or geriatr*) or (gender or sex) or ((urban
or rural or (inner-city OR slum)) or (race or ethnic* or (aboriginal OR indigenous OR refugee)) or (occupation or blue-collar))))
and((specific or subgroup or sensitivity) or ((equit* OR inequit*) or disparit* or inequalit*) or (factor or difference))
Sociological abstracts- 1005
(((meta-analys* or (systematic review) or meta-epidemiol* or meta-synthes*) and (religio* or cultur* or (education status) or (education
attainment) or literacy or (socioeconomic status) or poverty or low-income) or (developing countries) or africa or (China OR South
America OR Asia OR Eastern Europe) or (homosexual or lesbian) or(elderly or geriatr*) or (gender or sex) or (urban or rural or
(inner-city OR slum)) or (race or ethnic* or (aboriginal OR indigenous OR refugee)) or (occupation or blue-collar)))) and( (specific
or subgroup or sensitivity) or (equit* OR inequit*) or disparit* or inequalit*) or (factor or difference))
Cochrane Methodology Register: 149 records
(((meta-analys* or (systematic review) or meta-epidemiol*) or meta-synthes*) and ((religio* or cultur*) or ((education status) or
(education attainment) or literacy) or ((socioeconomic status) or poverty or low-income) or ((developing countries) or africa or (China
OR South America OR Asia OR Eastern Europe)) or (homosexual or lesbian) or(elderly or geriatr*) or (gender or sex) or ((urban
or rural or (inner-city OR slum)) or (race or ethnic* or (aboriginal OR indigenous OR refugee)) or (occupation or blue-collar))))
and((specific or subgroup or sensitivity) or ((equit* OR inequit*) or disparit* or inequalit*) or (factor or difference))
Cochrane HTA database, 156 records
(((meta-analys* or (systematic review) or meta-epidemiol*) or meta-synthes*) and ((religio* or cultur*) or ((education status) or
(education attainment) or literacy) or ((socioeconomic status) or poverty or low-income) or ((developing countries) or africa or (China
OR South America OR Asia OR Eastern Europe)) or (homosexual or lesbian) or(elderly or geriatr*) or (gender or sex) or ((urban
or rural or (inner-city OR slum)) or (race or ethnic* or (aboriginal OR indigenous OR refugee)) or (occupation or blue-collar))))
and((specific or subgroup or sensitivity) or ((equit* OR inequit*) or disparit* or inequalit*) or (factor or difference))
Digital dissertations, 98 records
(((meta-analys* or (systematic review) or meta-epidemiol*) or meta-synthes*) and ((religio* or cultur*) or ((education status) or
(education attainment) or literacy) or ((socioeconomic status) or poverty or low-income) or ((developing countries) or africa or (China
OR South America OR Asia OR Eastern Europe)) or (homosexual or lesbian) or(elderly or geriatr*) or (gender or sex) or ((urban
or rural or (inner-city OR slum)) or (race or ethnic* or (aboriginal OR indigenous OR refugee)) or (occupation or blue-collar))))
and((specific or subgroup or sensitivity) or ((equit* OR inequit*) or disparit* or inequalit*) or (factor or difference))
Appendix 3. Data extraction form items
Ref ID
Author
Year
PROGRESS dimension
Definition equity (by author)
How is judgment of equity made? Ie fairness and avoidability?
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(Continued)
Proxy measures used for PROGRESS-Plus? (e.g. nutritional status)
Reason/rationale for assessing equity
Number meta-analyses
Quality: Selection bias: how was sample of systematic reviews selected? Is there likelihood of selection bias?
Quality: Attrition bias: potential for bias in the exclusion of systematic reviews from analysis. Were any systematic reviews excluded
and why
Quality: Detection bias: potential for bias in the assessment of analytic methods and outcomes in cohorts of systematic reviews. How
did studies extract details of analysis of effects on health equity
outcomes (benefits, harms, costs)
Quant measure of gaps/gradients
Statistical methods used (e.g. meta-regression, subgroup analysis)
Methods of comparing gap (relative, absolute, gradient, risk difference)
Describe whether PROGRESS+ is mentioned in SR- in introduction, methods, discussion
Describe whether SRs describe population across PROGRESS+
Describe whether SRs include studies of targeted interventions aimed at disadvantaged
Describe outcomes related to equity of coverage or access
Describe whether primary studies included in the SRs stratify analyses by PROGRESS
Describe whether subgroup analyses were planned or conducted across PROGRESS in the SRs
Subgroup analysis described in sufficient detail to answer 7 questions
Analytic- assess association of PROGRESS+ factor with effect size
Analytic: compare effect size between two groups using odds ratio, risk difference, relative risk
Analytic- assess likely impact on disadvantaged populations using checklists for applicability
Effect size
Standard error
95% CI
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(Continued)
Expertise required to assess equity effects (as described by author, or paste in methods)
Availability of data to assess equity gap (as described by author)
Useability for end-user? (judgment by extractor or paste author’s description
Advantages of method chosen to assess gap, as described by author?
Disdavantages of method chosen to assess gap, as described by author?
Clinically important difference?
Statistically significant difference?
A priori hypothesis
Subgroup analysis is one of small number of hypotheses tested?
differences suggested by within study comparisons
Difference consistent across studies?
Indirect evidence to support hypothesis?
Implications for policy, practice, research based on equity, equality analysis?
How was this study found? (searching databases, handsearching etc
Factors associated with equity differences (e.g. study design, implementation adherence, compliance)
Limitations as described by author
Strengths as described by author
Appendix 4. SUPPORT Collaboration checklists for applicability, equity and scaling up
Available from: http://www.support-collaboration.org/summaries/methods.htm
APPLICABILITY
Consider differences in:
· structural elements of health systems (such that an intervention could not work in the same way)
· on-the-ground realities and constraints (that might substantially alter the potential benefits of the intervention)
· baseline conditions (different absolute effects, even if the relative effectiveness was the same)
· perspectives and influences of health system stakeholders (such that the intervention may not be accepted or taken up in the
same way)
EQUITY
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· Are there plausible reasons for anticipating differences in the relative effectiveness of the intervention in disadvantaged settings
within the country?
· Are there likely to be different baseline conditions within the country, so that the problem would be more or less important in
disadvantaged settings within the country?
· Are there likely to be different baseline conditions in disadvantaged settings within the country, so that the absolute effectiveness
would be different?
· Are there important considerations that should be given to implementing the intervention to ensure that inequities are not
increased and that they are reduced
SCALING UP
· What are the most important economic consequences?
· What information is there about the total resource implications of expanding coverage and sustaining an intervention?
· Is there important uncertainty about medium to long-term economic consequences?
· Is there important uncertainty about the applicability of any reported economic consequences?
Appendix 5. Scottish Intercollegiate Guidelines Network [SIGN] grades of assessment
Grade Assessment of individual studies
1++ High quality meta analysis, systematic review of randomized controlled trials (RCT), or RCT with very low risk of bias
1+ Well-conducted meta analysis, systematic review of RCTs, or RCT with a low risk of bias
1- Meta analysis, systematic review of RCTs, or RCT with a high risk of bias
2++ High quality systematic reviews of case-control or cohort studies, High quality case-control or cohort studies with a very low risk
of confounding, bias, or chance and a high probability that the relationship is causal
2+ Well conducted case control or cohort studies with a low risk of confounding, bias, or chance and a moderate probability that the
relationship is causal
2- Case control or cohort studies with a high risk of confounding, bias, or chance and a significant risk that the relationship is not
causal
3 Non-analytic studies, e.g. case reports, case series
4 Expert opinion
Assessment of all evidence for each intervention
A: At least 1 meta analysis, systematic review, or RCT rated as 1++, directly applicable to the target population; or a systematic review of
RCTs or a body of evidence consisting primarily of studies rated as 1+, directly applicable to the target population and demonstrating
consistent overall results
B: Body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating consistent overall
results; or extrapolated evidence from studies rated as 1++ or 1+
C: Body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating consistent overall
results; or extrapolated evidence from studies rated as 2++
D: Body of evidence 3 or 4; or extrapolated evidence from studies rated as 2+ D
Appendix 6. SIGN Considered Judgment Form
Considered judgement on quality of evidence
Key question: Evidence table ref:
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(Continued)
1. Volume of evidence
Comment here on any issues concerning the quantity of evidence available on this topic and its methodological quality.
2. Applicability
Comment here on the extent to which the evidence is directly applicable to the NHS in Scotland.
3. Generalisability
Comment here on how reasonable it is to generalise from the results of the studies used as evidence to the target population for this guideline.
4. Consistency
Comment here on the degree of consistency demonstrated by the available of evidence. Where there are conflicting results, indicate how the
group formed a judgement as to the overall direction of the evidence
5. Clinical impact
Comment here on the potential clinical impact that the intervention in question might have - e.g. size of patient population; magnitude of
effect; relative benefit over other management options; resource implications; balance of risk and benefit.
6. Other factors
Indicate here any other factors that you took into account when assessing the evidence base.
Appendix 7. Biological plausibility and feasibility in LMIC grades of evidence
I. Evidence of nobenefit. Interventions forwhich evidence exists showing they have no important benefits-either singly or in combination
with other measures-for perinatal or neonatal health.
II. No evidence of benefit. Interventions for which evidence for or against an effect was absent.
III. Uncertain evidence of benefit. Interventions for which there was some evidence of benefit, but contradictory evidence, or issues
such as study design, location, or size precluded any firm conclusions. These interventions merit further assessment in low-income and
middle-income countries.
IV. Evidence of efficacy. Interventions effective in reducing perinatal or neonatal mortality, or primary determinants thereof, but there
is a lack of data on effectiveness in large-scale programme conditions.
V. Evidence of efficacy and effectiveness. Interventions of incontrovertible efficacy andwhich seem feasible for large-scale implementation
based on effectiveness trials.
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S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Canadian Institutes of Health Research doctoral fellowship, Canada.
Funding for doctoral degree from government of Canada
• Department of Health (England), UK.
Cochrane systematic review incentive program
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We clarified our inclusion criteria by stating that we are explicitly not including studies with surrogate outcomes for health (e.g.
vaccination rates and high risk behaviours), as follows: We excluded studies which measured inequalities in surrogate outcomes for
health across PROGRESS-Plus factors such as vaccination rates (Shea 2009) or high-risk behaviours (Vergidis 2009a).
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Health StatusDisparities; ∗ReviewLiterature asTopic; Age Factors; Continental PopulationGroups;DevelopingCountries; Ethnology;
Research Design [standards]; Sex Factors; Socioeconomic Factors
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MeSH check words
Humans
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